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Abstract 
Obesity is increasingly recognised as a major health threat in the developed world, with 
more than 120 million people worldwide classified as clinically obese. Increased weight 
causes increased morbidity and mortality due to its association with cardiovascular 
disease, diabetes and certain cancers. Bariatric surgery is currently the most efficacious 
treatment for morbid obesity and has the best long-term outcomes. Bariatric surgery is 
not without risks. Some of the early risks include postoperative bleeding, anastomotic 
leaks, and venous thromboembolism. Late complications include marginal ulcer 
formation, nutritional deficiencies and small bowel obstruction. The latter may be caused 
by internal hernia formation. 
 
In this thesis, an analysis of the causes of small bowel obstruction after laparoscopic 
Roux-en-Y gastric bypass (LRYGB) is presented, looking specifically at internal hernia 
formation. A detailed account of the presentation and radiological findings of internal 
hernia following laparoscopic gastric bypass is provided. The impact of altering surgical 
technique on the occurrence of internal hernia is analysed: an Observational Clinical 
Human Reliability Assessment (OCHRA) tool was used for root cause analysis of 
internal hernia following gastric bypass and in the final study, the employment of a new 
technique demonstrated significant reduction in the incidence of internal hernia. 
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1. LITERATURE REVIEW 
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1.1 Impact of obesity 
Obesity is a worldwide problem, taking on pandemic proportions – it has been estimated 
that in the United States of America 30.5% of people are obese and 64.5% are overweight 
(1). Body mass index (BMI) is the preferred method by the WHO to define obesity and it 
is calculated using weight in kilograms divided by height in meters2, expressed as kg/m2 
(2). A BMI above 25kg/m2 defines overweight and above 30kg/m2 obese. Morbid obesity 
begins at 40 kg/m2, and super obesity at a BMI of 50 kg/m2. The picture in the UK in 
2001 was equally alarming as 21% of men and 20% of women were found to be obese in 
the Health survey for England and Wales (3).  Collectively, data from both the US and 
UK suggest an exponential rise in obesity. Data from the Department of Health predicted 
UK obesity rates to rise drastically such that in 2010, 6 million women and just under 7 
million men would be classified as obese (BMI > 30kg/m2) (4). According to the latest 
Lifestyle Statistics published by the Information Centre for the NHS in 2009, 24% of 
adults (aged 16 or older) in England were classified as obese and the current population 
of morbidly obese (BMI > 40kg/m2) in England has been estimated to be approximately 
1.2 million i.e. 2% of the total population (5). 
 
In the mid-1950s, data obtained from the insurance industry in the US indicated that 
intentional weight loss may have some health benefit.  People applying for life insurance 
had to supply their height and weight, and overweight subjects were asked to pay higher 
insurance premiums if they decided not to lose some of their excess weight. Both the 
group that underwent intentional weight loss and the group that decided not to lose 
weight (but instead paid the higher insurance premiums) were followed until their death. 
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The intentional weight loss group showed a significant health benefit. A recent 
observational case control study supplied the strongest evidence to date that intentional 
weight loss leads to health benefits as in a cohort of 6391 people questioned, those who 
reported intentional weight loss had the lowest mortality (6). This observation, in fact, 
formed the basis for the Swedish Obese Subjects study, which is described later (7). 
 
Although BMI as a measurement is the preferred choice of the World Health 
Organisation for epidemiological quantification of obesity, as alternative options are 
costly and not universally available (2). However, it is not without its problems. This 
definition has been criticised as it reflects the health outcome of a Caucasian population 
(8). If BMI is used to compare health outcomes of obese Caucasians and South Asians it 
becomes clear that the latter is subject to complications of obesity at BMIs of 
approximately 28kg/m2, while the BMI definition of obesity for a Chinese population 
should probably be as low as 26kg/m2(8). Thus, recording waist circumference has been 
gaining popularity, as this may be a better surrogate marker, at least with regards to 
obesity associated cardiovascular morbidity (9). As such, in males a waist circumference 
of >40 inches and in females >32 inches is classified as high risk. 
 
It is widely acknowledged that those who are classified as overweight or obese have an 
increased risk of diseases. The risk of developing Type 2 Diabetes is 20 times greater for 
people with severe obesity (BMI > 35kg/m2) than for those with a BMI between 18-25 
kg/m2 (10,11). Ten percent of all cancer deaths amongst non-smokers are attributed to 
obesity (12).  The risk of coronary heart disease increases 3.6 times for each unit increase 
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in BMI (13).  Also, 85% of all hypertension cases are amongst individuals with BMI > 
25kg/m2 (11).  Although these co-morbidities contribute greatly to the mortality 
associated with obesity, other conditions such as osteoarthritis, gallbladder disease, 
obstructive sleep apnoea and subfertility further exacerbate the morbidity burden (14). 
These together with the personal and professional discrimination affecting obese 
individuals, challenge the belief that anyone would choose to become obese or that 
obesity is the result of greediness or lack of self-control (15). 
 
It has also been stated that morbidly obese individuals (i.e. BMI > 40kg/m2) are likely to 
die on average 11 years earlier than a healthy weight individual (16). This is comparable 
to, and in some cases worse than, life reduction as a result of smoking (16). Given the 
wide range of diseases and conditions, which are directly attributable to obesity, it is not 
surprising that obesity places a significant financial burden on the NHS. It has been 
estimated that direct costs are approximately £4.2 billion per annum and forecasts suggest 
that this will double by 2050 (17). This does not take into account the even greater 
indirect costs due to the loss of productivity, sickness benefits etc. Obese patients 
consume a significantly higher proportion of health care - an adult obese patient will 
generate 27% more ambulatory care spending than a non-obese patient of the same age 
(18). The highest cost drivers are those relating to the management of co-morbidities 
associated with obesity; t is estimated that obesity accounts for 85% of the total cost of 
treating type II diabetes, and 45% of the costs of treating hypertension (16). 
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1.2 Treatment options for obesity 
The goal when treating severe obesity should be to improve the patient's health by 
helping them achieve and maintain a weight loss routine that prevents and reduces the 
risk of life-threatening factors and improves performance of activities of daily living. 
Treatment options include those targeted through diet, pharmacology and surgery and 
will be discussed in further detail. 
 
1.2.1 Weight loss through dieting 
The loss and subsequent regain of weight have been examined in studies such as the 
Minnesota  Men’s  Study  (19). This study was set up following the Second World War to 
investigate the best way to regain weight following severe starvation. The study was 
commissioned by the US government and utilised conscientious objectors who 
volunteered to be placed in a converted football stadium where they were subjected to 
very low calorie diets over a prolonged period. Following the period of starvation 
different methods were used to regain weight. During the weight loss phase the subjects 
lost fat and lean mass and showed a decrease in resting metabolic rate as well as 
unconscious movement, while during the weight regain phase they replaced their fat 
stores before replacing their muscle mass (19). This is a pattern, which repeats itself and 
can also be observed in the so-called “yo-yo” dieting (20).  
 
Results of intentional weight loss and weight maintenance following lifestyle changes 
have been disappointing (3). Many studies have explored the combined benefit of low 
calorie diet, with either exercise or behavioural therapy. Most of these studies report only 
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short-term effects with a degree of weight loss. However, studies reporting long term 
follow up data demonstrate that the excess weight invariably returned to similar, or even 
higher levels (7). It can be argued that this is simply consistent with evolutional change 
amongst early humans who lived in hunter-gatherer societies. These humans experienced 
continuous cycles of feast and famine and this may have resulted in an evolutionary 
advantage for those that could in times of famine still function during hunger, while also 
being able during times of feast to replace all the weight loss and even increase their 
weight above previous levels to serve as a buffer against possible future famine (21, 22). 
 
This may also contribute to the yo-yo dieting pattern so commonly observed. Nowadays, 
humans are no longer exposed to feast or famine cycles as for most in the developed 
world there is a continuous and abundant supply of food. However with the self-imposed 
restrictions of low calorie diets the same hunger signals that our ancestors experienced 
are invoked, thus, leading to a similar response of weight regain when the diet is 
discontinued (20). 
 
1.2.2 Weight loss utilising pharmacotherapy 
The role of pharmacotherapy in weight loss remains controversial. Obesity is viewed by 
many as a result of poor will power and should, on these grounds, not be considered for 
pharmacotherapy. However, the same argument was levelled at hypercholesterolaemia 
and it was only after effective agents became available to treat this co-risk factor for 
cardiovascular disease that pharmacotherapy was more widely accepted.  Large 
pharmaceutical companies are heavily investing in drugs to target obesity. To date, no 
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one has been able to elucidate which components of the complex system controlling 
energy homeostasis and weight maintenance should be targeted. Thus a remarkable 
redundancy exists in the processes regulating energy homeostasis and weight 
maintenance.  This, together with the possible detrimental influence of drugs on health, 
has prevented many agents making it to market so far. 
 
Currently only two agents are available. The first, orlistat, a lipase inhibitor, prevents up 
to 30% of the absorption of fat by the gastrointestinal system (23). The mechanism of 
weight loss however, is not directly linked to the pharmacodynamics, but more to the 
effects of when fatty food is ingested while orlistat is being used. The resulting diarrhoea 
or oily leak is unpleasant enough to discourage the continuation of a high fat diet. The 
patient, if well informed, will usually revert to a lower fat, less energy dense diet with a 
resulting decrease in weight. Yet weight loss on orlistat therapy is not a universal 
phenomenon as many perpetual dieters taking the medication consume low fat foods, thus 
avoiding the side effects, but because of the volume of these meals, still have an energy 
surplus. Orlistat has recently been made available as over the counter medication in the 
UK (24). 
 
Sibutramine was available until recently but the European Medicines Agency (EMA) has 
suspended its license due to an increased risk of adverse cardiovascular effects. This 
noradrenaline and serotonin reuptake inhibitor was originally designed to be an 
antidepressant (23). The initial phase I and II trials, however, showed that the 
antidepressant effect was weak, but that a significant appetite reduction occurred. Yet the 
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side effect profile has caused some concern, as a number of patients are not able to 
tolerate the medication due to its noradrenalergic effects causing insomnia and 
gastrointestinal disturbances (25). Physicians were also obliged to check blood pressure 
on a regular basis and to withdraw patients from treatment when systolic or diastolic 
blood pressure increased by 10mmHg (25).   
 
Another drug, Rimonabant, also had its license suspended by the EMA due to an 
increased risk of serious psychiatric disorders. This drug, like sibutramine, is a centrally 
acting drug. It is a cannabinoid one (CB1) receptor blocker and acts on the CB1 
receptors. The CB1 receptors are found in the hypothalamus and are involved in 
controlling our intake of highly palatable, sweet or fatty foods. Over-activation of the 
CB1 receptors is associated with increased appetite, cravings for food and fat build-up. 
Rimonabant blocks CB1 receptors, thus, reducing cravings for these types of foods and 
helps control hunger and decrease appetite. This again helps decrease the overall calorie 
intake and results in weight loss. Furthermore, Rimonabant seems to have other 
beneficial effects including improving diabetes control and lowering cholesterol. It has 
also been shown to help people give up smoking. The drug, however, comes with 
psychiatric adverse effects including depression, anxiety, agitation and sleep disorders. It 
is contraindicated in people with active psychiatric illnesses and it may increase risk of 
suicide (25). It is for these reasons that its license was suspended by the EMA. 
 
The second class of drugs that may be used to obtain weight loss specifically in type 2 
diabetics are the glucagon-like peptide (GLP-1) agonists Exenatide and Liraglutide which 
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have to be injected subcutaneously. Both function as incretin mimetics by stimulating 
glucose-dependent insulin secretion, inhibiting glucagon secretion and suppressing 
appetite. The expected weight loss is about 5Kgs with one year of treatment.  
 
It is predicted that pharmacotherapy will continue to show rapid growth as most lifestyle 
interventions have been shown to be ineffective if not applied in conjunction with 
pharmacotherapy. Several new drugs and classes of drugs are in the pipeline for future 
use against the epidemic of obesity and the situation currently may be analogous to the 
early 1960s when patients with hypertension had to be treated with crude diuretics or 
centrally acting agents. The side effect profiles of these medications were significant, but 
with further development of the drugs a substantial useable health benefit may be 
achievable. 
 
1.2.3 Weight loss utilising surgical interventions 
Surgical interventions for weight loss – also referred to as bariatric surgery – have proven 
to be the most effective methods for intentional weight loss and post weight loss 
maintenance (26-29). Weight loss surgery is not a cosmetic procedure and does not 
involve the removal of adipose tissue. Instead, the rationale for the original interventions 
was based predominantly on either restricting the progression of food through the 
gastrointestinal system, or by causing some form of malabsorption, or a combination of 
the two. However, interestingly, it has been shown that animals undergoing such 
procedures have a marked reduction in appetite (30-33), a result which has also been 
observed in humans (27,28,33). The three possible mechanisms causing the reduction in 
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appetite include neural, psychological and humoral factors. It is most likely that all three 
factors play a role in this appetite suppression, and this concept for the cause of such 
significant weight loss is gaining popularity. 
 
Before patients can be considered for surgery it is vital that they have been treated with 
traditional methods such as diet, exercise and in some cases with pharmacological 
methods. For a small proportion of the severely obese population these methods may 
result in weight loss that is sustained and is beneficial to their health, but for the majority 
weight loss is not maintained. One report documents that non-surgical methods alone 
only work for 1 out of 20 severely obese individuals: fewer than 5% show any significant 
weight loss which they are able to maintain in the long run (34). In a study carried out 
over a period of nearly four years, which utilised a two-drug regime, behaviour 
modification, diet and exercise, the initial positive results were not sustained. There was a 
dropout rate of one third and for those individuals who followed the study throughout the 
four years, the average final weight loss was only 3lbs or 1.4 kg (35). 
 
For the right group of patients, surgery leads to significantly greater, and sustained, 
weight loss than that achieved with non-surgical treatments. This leads to the resolution 
of, or significant improvement of, many weight related diseases and conditions which in 
turn  leads  to  increasing  a  patients’  life  expectancy  and  significantly improving their 
quality of life. Bariatric surgery is complex and highly specialised, and it is performed in 
an extremely high-risk group of patients. The specific operative complications will be 
discussed in detail (See Chapter 2). Given the life-altering post-operative sequelae, in 
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terms of both the potential complications and the impact surgery can  have  on  patients’  
lives,  the  decision  to  operate  should  not  be  taken  lightly.  There  has  to  be  complete  “buy-
in”  from  the  patient  and  their  family  – they must commit to the post-operative regime to 
try and prevent potentially life-threatening complications such as pulmonary embolism, 
which given their high BMI they are at increased risk of (36, 37, 38). The recovery period 
is long, they are not able to eat solids for weeks after their surgery, and even once they 
have healed they will never be able to eat in a normal way again. There are also the 
psychological  factors  that  take  place  as  the  patient’s  body  habitus  alters  as the weight is 
lost, and some patients’ personal relationships improve, but also they can break down 
(39). That said, for some patients, this surgery provides them with a new lease of life 
(39).  
 
1.2.4 History of weight loss surgery 
There are currently three common bariatric operative procedures, the gastric banding, 
sleeve gastrectomy and Roux-en-Y gastric bypass. It is important to consider the more 
dated techniques, in order to fully understand the rationale behind their conception. Jaw 
wiring was first used in the mid-1970s and it was used to restrict the opening of the 
patient’s  mouth,  thus  making  the  consumption  of  a  usual  meal  impossible.  These  patients  
could only consume liquid meals by using a straw. This highly regimented protocol 
ensured dramatic weight loss as the liquid diet contained far fewer calories (40). This 
form of surgical intervention was accompanied by a behaviour modification programme, 
which tried to teach the patients to follow a low calorie diet after the removal of the jaw 
wires. However, the end results were very disappointing; although all the patients lost 
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significant amounts of weight while their jaw movement was restricted, they invariably 
regained all the weight after the wires were removed (40).  
Henrikson in 1950 was the first to describe an abdominal surgical procedure for obesity 
consisting of a massive small bowel resection, leaving a short bowel (41). This led others 
to perform bypasses of the small intestine. The Jejuno-Ileal (JI) bypass, in various forms 
became a popular operation in the 1970s for severe obesity (42-44). However, the JI 
bypass was associated with serious complications such as blind loop syndrome due to 
bacterial overgrowth, abdominal bloating, migratory arthralgias, urinary stones, and, 
unless adequate protein was consumed, liver problems (45).  
 
In order to perform an operation without the side-effects of the JI bypass, in the mid-
1960s, Mason developed the gastric bypass, using a horizontal divided gastric pouch, 
joined to a loop of jejunum (46). Since the resultant gastrojejunostomy anastomosis was 
often under tension, Griffen developed the Roux-en-Y gastric bypass (RYGB) to help 
prevent this (47). Torres made a further modification to this - a vertical pouch on the 
lesser curvature of the stomach (48). The RYGB has undergone many modifications since 
and it is the most common operation in the USA for effective weight loss (49). The 
laparoscopic technique applies itself effectively to RYGB and its popularity continues to 
increase primarily since when compared to the traditional open approach it has fewer 
perioperative complications, a shorter hospital stay, and a more rapid recovery time than 
open surgery (50-52).      
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Around the same time as the bypass was being developed, Scopinaro in Italy developed 
the Bilio-Pancreatic Diversion (BPD), with the intent to avoid the problems associated 
with the blind loop formed after JI bypass. This primarily malabsorptive operation only 
allows for the absorption of carbohydrates and fats in the distal 50-70cm of the ileum. 
BPD has been reported to provide the highest long-term weight loss of any bariatric 
operation, however patients need close long-term post-operative follow-up for protein, 
vitamin and mineral deficiency as this remains as a significant complication following 
this surgery (53). The BPD was modified by Marceau and Hess to the duodenal switch 
(DS). In this procedure a vertical gastric tube, or sleeve, remains along the lesser curve of 
the stomach. The 1st part of the duodenum is divided 3cm distal to the pylorus; the 
proximal duodenum is then anastomosed to the ileum, which has been divided 250cm 
proximal to the ileocaecal valve. The proximal end of the biliopancreatic limb is blind-
ending, and the distal end of the biliopancreatic limb is anastomosed to the side of the 
ileum 75-100cm proximal to the ileocaecal valve, which becomes the common channel. 
The intact pylorus reduces the risk of dumping syndrome. 
 
The DS in the super-super obese patients who were very high-risk used to be performed 
as a staged procedure. Stage one would involve creation of the gastric tube or sleeve. The 
patient would then experience some weight loss from this process alone, and then would 
return to the operating room for stage two, which would involve the more complex 
intestinal reorganisation. In fact, the weight loss seen from stage one was so impressive 
that this stomach reduction, or sleeve gastrectomy, has gained popularity in its own right 
as a primary weight loss surgery  (laparoscopic sleeve gastrectomy). It is now being 
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performed increasingly as a stand-alone procedure with the surgeon having the option to 
add the DS portion or RYGB as a second operation if there is any future weight gain (54). 
A recent consensus meeting on the sleeve gastrectomy reports impressive results with this 
operation as weight loss and health benefits are in line with those seen after LRYGB (55). 
 
In the 1980s, in the search for a simpler technique, gastric restrictive procedures to limit 
intake were developed by Carey and Gomez (56, 57). These involved stapling across the 
stomach below the GOJ leaving a reduced size gastric food reservoir, and only a central 
gap in the staple line to allow food intake to pass through. However, the small horizontal 
pouch enlarged as did the outlet. Mason in 1982 reported the vertical banded gastroplasty 
(VBG) in which a stapled but non-divided vertical pouch along the lesser curve of the 
stomach is formed.  The outlet from this pouch into the gastric remnant is restricted by a 
non-dilatable band or mesh. This technique continues to be performed with various 
modifications, yet its popularity has decreased due to frequent regain of weight in the 
long term usually a consequence of failure of the pouch staple line. 
 
In the early 1980s, Molina in the USA developed gastric banding as a restrictive 
procedure with a band placed high around the stomach, producing a tiny pouch (58).   
Subsequently, others developed an inflatable gastric band attached by tubing to a 
subcutaneous reservoir through which saline could be instilled or withdrawn via a tiny 
needle to control band size in order to adjust its tightness around the body of the stomach 
(59,60) (Figure 1.1). The normal course of events is for the stomach pouch to dilate and 
for the band to loosen as the fat around the stomach decreases. The result is a looser 
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fitting band, which allows the patient to become hungrier and to consume more food, 
followed by weight regain. In such circumstances, the band is filled and the restriction 
around the stomach restored (61).  With the band operation, patient selection is very 
important  as  disorders  such  as  bulimia  nervosa  or  “binge  eating  disorder”  may  have a 
higher complication rate and less overall excess weight loss (62). It is usual for patients to 
experience some post procedure vomiting as the stomach perceivable volume is suddenly 
so much smaller than what the patient is used to and they are not accustomed to the 
significantly reduced amount of food that can be tolerated safely.  
 
 
Figure 1.1 Gastric Band 
 
Another procedure that aims to restrict the food consumed is the placement of an 
intragastric balloon (63). This is inflated within the stomach and thus reducing the 
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potential space for food. The complication rate is significant with balloons bursting or 
causing obstruction. The presence of the balloon can also cause severe vomiting if too 
much food is consumed. Weight loss is not maintained as unlike in other procedure, 
appetite is not normally affected and therefore the patient remains hungry while the 
balloon is in place and can consume large amounts of food when the balloon is removed. 
This procedure is used in some units as a method to prepare extremely obese patients for 
other forms of more definitive weight reducing surgery. 
 
More recently, gastric pacing is being researched following the work of Cigaina (64). 
Two electrodes are positioned in the muscle of the anterior gastric wall at the lesser 
curvature, and are connected to leads attached to a subcutaneous electrical generator.  
This  ‘pacemaker’  stimulates  its  own  rhythmic  gastric  waves,  and produces satiety, and 
reduces the plasma levels of Ghrelin.  The initial results available from using this 
technique have demonstrated some weight loss, although long term maintenance results 
are awaited (65).  
 
More  recently,  GI  Dynamics’  EndoBarrier  Gastrointestinal  Liner  System  is  an  
endoscopically-delivered device that offers an alternative approach (66). The device 
shields the duodenum and upper jejunum from contact with chyme, thereby mimicking 
the  foregut  bypass  effect  of  a  gastric  bypass  procedure  without  altering  the  patient’s  
anatomy. Pancreatic and biliary secretions pass along the outside of the devices and then 
mix with chyme in the upper jejunum. Based on animal experiments and clinical 
observations, the EndoBarrier Gastrointestinal Liner may provide a useful non-surgical 
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intervention for treating type 2 diabetes with an added benefit of providing weight loss, 
however there is not yet sufficient volume of evidence to demonstrate this conclusively in 
humans (66).   
1.2.5 Common types of weight loss surgery 
Currently, the three most common bariatric procedures performed worldwide are the 
Gastric band, the gastric bypass and the sleeve gastrectomy (49).  
1.2.5.1 Gastric Band  
This procedure has already been discussed above (1.2.3.1). As a restrictive procedure, by 
creating a small upper-stomach pouch it limits food intake by decreasing hunger and 
increasing the feeling of fullness after meals. The precise mechanisms underlying weight 
loss are still unclear but it has been hypothesized that due to presumed pressure on the 
vagus nerve from the band, hunger is reduced (67). The best results are seen when the 
band is sequentially adjusted at regular intervals to provide optimal reduction in hunger 
and increased fullness, which is inextricably linked with good patient compliance with 
the post-operative program. This then will lead consistently lower caloric intake and 
reliable weight loss will follow. Gastric banding were originally an operation of choice in 
patients without significant comorbidities, and who were just simply obese. The idea of a 
solution that is removable and does not require any irreversible anatomical alteration also 
appealed to some patients. It is, overall, losing popularity, however, since it is expensive, 
not without complication and easily abused by patients who then do not get sustained 
weight loss thus defeating the purpose of the surgery (49). 
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1.2.5.2 Gastric Bypass  
The gastric bypass is the most common bariatric procedure performed worldwide.  It is 
increasingly performed laparoscopically. The gastric bypass operation commences with 
formation of the vertical gastric pouch some 15-20 mls in size.  Dissection starts along 
the lesser curve, and the retrogastric adhesions and angle of His are freed.  Sequential 
firings of a stapler create a vertical gastric pouch. There has been much research into the 
size of the pouch. A retrospective study has suggested that smaller pouches may be 
associated with greater weight loss, although accurate measurement of pouch volume is 
difficult and prospective data are lacking (68). Most surgeons choose the transection 
point by measuring from the oesophago-gastric  junction  as  accurately  as  simply  “eye-
balling”  the  anatomy,  or by counting vascular arcades. If too large, it can cause an 
increase in the rate of marginal ulceration and reduced weight loss.  
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Figure 1.2  Roux-en-Y gastric bypass 
Having created the pouch, the next step is to alter the configuration of the small bowel. In 
order to create the Roux-en-Y bypass, first the jejunum is divided at a point typically 30-
40 cm distal to the ligament of Treitz. The distal segment is then moved cephalad to form 
the alimentary or Roux limb, and is surgically connected to the gastric pouch. This 
segment can either be brought ante or retro-colic, (in front of or behind the colon), and 
ante or retro-gastric (in front of or behind the stomach) and there are different techniques 
in use for the formation of the gastrojejunostomy. These include a handsewn or stapled 
approach, with the latter using either a straight (linear) or circular stapler. Each of the 
different techniques have been assessed in the literature and care should be taken when 
choosing the approach as there is a varying associated risk of stenosis and leak (69). 
Benefits of the ante-gastric route include the relative increased ease of accessing the 
anastomosis and re-examining it if necessary at subsequent surgery, particularly in 
revision or re-look surgery since it is not hidden underneath the stomach. However, if the 
patient has a short mesentery, this can mean that there is extra tension put on the 
anastomosis thus increasing the risk of leak. In these circumstances, a retro- approach is 
usually better. The proximal bowel segment, also called the biliopancreatic limb, is 
usually connected to the alimentary limb 75-150cm distal to the gastrojejunostomy, thus 
creating the common channel (Figure 1.2.).  
 
Several authors have addressed the issue of alimentary limb length during RYGB. For 
patients with a BMI of 50 kg/m2 or less, there is no proven benefit for alimentary limbs 
longer than 150cm (70). Other studies examining the use of alimentary limbs longer than 
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250cm for patients with a BMI greater than 50kg/m2 have found improved weight loss 
over standard RYGB, but if greater than 300cm there is increased nutritional deficiencies 
and need for reoperation (70). 
 
 
One of the consequences of performing a RYGB is the creation of mesenteric defects in 
the transverse mesocolon if it is a retrocolic Roux limb, the small bowel mesentery for 
the formation of the jejunojejunostomy  or  through  Petersen’s  defect. The latter defect is 
between the mesentery of the Roux limb and the transverse mesocolon. Loops of small 
intestine may become trapped in such defects thus  forming  “internal  hernias”,  and give 
rise to small bowel obstruction. Internal hernias are more commonly observed in the 
laparoscopic approach rather than the open RYGB. This has been postulated to be a result 
of the fewer adhesions found in the laparoscopic technique (71). The closure of these 
defects at the primary operation is not performed universally by all surgeons, but 
traditionally has been recommended by most surgeons (72,73). The RYGB is the most 
commonly performed operation due to its impact on obesity-related co-morbidities and 
also weight loss itself. Yet it is also a complex procedure with significant associated 
complications. The pros and cons of the operation will be discussed in detail later in this 
chapter. 
 
1.2.5.3 Sleeve Gastrectomy  
This operation involves converting the stomach into a long, thin tube by stapling it along 
its length and removing the excess stomach (Figure 1.3). As mentioned earlier it was 
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initially  the  first  stage  of  a  DS  operation  but  the  patient’s  resultant  weight  loss  and  
comorbidity reduction has resulted in it becoming a recognised stand alone operation. 
Unlike a gastric bypass where food enters a small pouch and then passes straight into the 
small bowel, the route the food follows after a sleeve gastrectomy is the same as the one 
followed prior to the surgery. As the stomach is smaller, it is able to hold less and 
stretches more quickly to give a feeling of fullness and satisfaction. Equally excision of 
the stomach fundus means that the ghrelin producing cells which drive hunger are 
removed. 
 
Figure 1.3 Sleeve gastrectomy 
 
1.2.6 Eligibility for weight loss surgery  
In accordance with the National Institute for Clinical Excellence NICE criteria bariatric 
surgery is considered for those people who have (74):  
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1. BMI  ≥ 35 kg/m2 with obesity related comorbidities (such as diabetes, sleep apnoea or 
joint problems)  
2. BMI  ≥40 kg/m2   
3. Have tried all other methods of losing weight (diets, exercise, medication) including 6 
months medically supervised programme but have not been able to sustain weight loss 
4. Have no specific medical or psychological reasons why they should not have this type 
of surgery 
5. Are fit enough to undergo an anaesthetic and surgery 
6. Understand the need for long-term follow-up 
In an update document, NICE now recommend all individuals with BMI  ≥50 to be 
directly considered for surgery without the need for a prior 6-month medically supervised 
weight loss (75). 
 
 
1.2.7 Pros and cons of weight loss surgery  
Long term clinical benefits –the pros of bariatric surgery 
1.2.7.1 Weight Loss 
Weight loss per se is likely to be the least important measure of bariatric surgical 
outcomes, although it is highly correlated with recognized risk factors and with patient 
satisfaction. Weight loss is conventionally expressed as percentage of excess weight loss 
(%EWL). "Excess" refers to the weight that exceeds actuarial standards of weight 
adjusted for height ('desirable' or 'ideal' weight) corresponding to minimal mortality. In a 
recent meta-analysis, mean EWL (and 95% CI) after biliopancreatic diversion was 70.1% 
(66.3-75.9%), gastric bypass 61.6% (56.7-66.5%), vertical banded gastroplasty 68.2% 
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(61.5-74.8%) and adjustable gastric banding 47.5% (40.7-54.2%) (76). There are few 
longitudinal (> 10 year) studies of laparoscopic adjustable gastric banding and none for 
laparoscopic sleeve gastrectomy. Weight loss after adjustable gastric banding has 
generally been greater in Europe and Australia than in the United States, with fewer 
operative complications (77-79), although some recent studies from the US have shown 
improved results (80). 
1.2.7.2 Survival Advantage 
Reducing mortality is the most important goal of bariatric surgery. In 2006, the Swedish 
Obese Subjects study, the first prospective controlled study designed specifically to 
assess mortality, reported significantly lower mortality over 13 years in patients who had 
undergone surgery than in those treated conventionally with the best medical therapy 
(81). Another study matched 7,925 surgical patients with the same number of severely 
obese non-surgical patients. The results were that long-term mortality decreased by 40% 
for the surgical group (82). Numerous other studies have also been published and using 
different types of data sources like death registries, case-control series and meta-analyses, 
also demonstrate reduced mortality risk after bariatric surgery (83-87).   However there 
is, like in many fields of surgery, a correlation between better outcomes in high volume 
centres as well as with the obese patients’  own  baseline  status.  Sicker patients get poorer 
outcomes. 
 
1.2.7.3 Co-morbidity Reduction 
Surgery results in long-term weight loss and significantly improves or resolves many 
obesity related co-morbidities. Purely gastric-restrictive procedures do not appear to have 
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the durability of co-morbidity reduction seen after diversionary operations (88-90). As an 
example, dyslipidemia is best corrected after biliopancreatic diversion (BPD), followed in 
effectiveness by gastric bypass and adjustable gastric banding. The same applies to Type 
2 diabetes resolution, which happens fastest and to the greatest extent after BPD, then 
RYGB, and then banding. With regards to Type 2 Diabetes a recent study compared 
patients who had received bariatric surgery with those who were receiving traditional 
treatment (diet, exercise, drugs) (91). The study showed that, after 2 years, 73% of those 
who had surgery no longer had diabetes compared to only 13% in the non-surgical group 
(91).  Furthermore, it has been known that diabetic patients’ insulin requirements, with or 
without the addition of oral hypoglycaemic agents, rapidly drop within days of surgery 
and certainly before any significant weight loss with certain types of bariatric procedures. 
The speed of resolution of diabetes after RYGB or BPD has been associated with changes 
in the levels of various gut peptides such as glucagon like peptide 1 (GLP-1) (92). 
 
For specific obesity related co-morbidities, a recent systematic review of 136 studies, 
which included over 22,000 patients, demonstrated (76): 77% resolution of type 2 
diabetes; 62% resolution of hypertension; 86% resolution of sleep apnoea; and 71% 
resolution of high cholesterol. Furthermore, patients who have undergone weight loss 
surgery have a 40% reduced risk of developing cancer (81), improved mobility, improved 
fertility (93), and many other benefits (94).  Several studies show that following weight 
loss surgery, both maternal and foetal outcomes are improved (95).  Interestingly, a 
recent study of 113 babies born after maternal bariatric surgery who were followed for 2-
18 years revealed a reduction of obesity to local population standards (96). 
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1.2.7.4 Economic benefits of weight loss surgery 
Weight loss surgery is effective in the treatment or improvement of a number of obesity 
related co-morbidities. In the future, therefore, there will be a reduction in the medical 
treatment of these co-morbidities for example reduction in prescribing costs, reduction in 
hospital visits, primary care interventions etc. A 2004 Canadian study demonstrated the 
economic benefit of weight loss surgery within 3.5 years as a result of reductions in direct 
healthcare costs. After five years, the total hospitalisation costs for those who did not 
have surgery was 29 % higher than for those who did (87).  
 
An independent cost effectiveness model demonstrates that the surgical treatment of 
obesity leads to a greater improvement in Quality of Life than traditional treatment, and 
that weight loss surgery represents good value for money (97). The model based on 
French costs shows that Adjustable Gastric Banding is cost saving in private clinics and 
cost effective in public hospitals compared to traditional treatment. Cost benefits are 
evident both from the first year of treatment, and after 5 years of follow-up. In 2006, 
NICE recommended that for weight loss surgery  the  “evidence suggests that surgery in 
general is a cost-effective intervention relative to a limited non-surgical management 
option in a typical  severely  obese  group”  (75). 
 
With regards to type 2 diabetes, it has been claimed that bariatric surgery is one of the 
major breakthroughs in diabetes care to have emerged since the discovery of insulin!  As 
such, the cost-effectiveness of bariatric surgery for diabetes has been evaluated in prior 
studies (98,100), but these studies have been limited by simplistic diabetes models with 
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parameter inputs derived from individual trials. Only one previous study of LRYGB has 
accounted for the future complications of diabetes (101).  
 
In contrast, the authors of one recent study found that bariatric surgery, based on 
currently available data, is cost-effective over the lifetimes of severely obese patients 
with diabetes (99). Bypass surgery had incremental cost-effectiveness ratios (ICERs) of 
$7,000/QALY and $12,000/QALY for severely obese patients with newly diagnosed and 
established diabetes; banding surgery had slightly higher ICERs of $11,000/QALY and 
$13,000/QALY for the two respective diabetic groups. The ICERs for both surgeries are 
very favourable since values below the $200,000/QALY threshold in the U.S. are now 
considered cost-effective. Other diabetes treatments, such as intensive glycemic and lipid 
control in comparison to conventional risk factor control, have previously been found to 
have ICERs of $41,384/QALY and $51,889/QALY. 
 
While these results are extremely promising for bariatric surgery, the validity of this 
analysis and others like it depends on the quality of the research in bariatric surgery. 
Unfortunately, bariatric surgery studies are plagued by inadequate patient retention and 
short durations of follow-up. The accepted standard for patient retention in both 
published studies and clinical practice is 50%, which is far below the norm for clinical 
studies in other areas of medicine. These low retention rates are highly problematic 
because they have the potential to introduce strong selection bias. Patient attrition after 
bariatric surgery is very likely related to satisfaction with the surgery and its effects. 
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Thus, reported results from bariatric surgery likely overestimate rates of diabetes 
remission and improvement and underestimate costs.  
 
In conjunction with the practice of allowing low retention rates, follow-up time for the 
majority of bariatric surgery studies is less than 2 years.  This short duration of follow-up 
is thought to be appropriate for most surgical research since complications usually occur 
within a few years of surgery. However, bariatric surgery can also cause lifelong side-
effects such as nutritional deficiencies, dumping syndrome, cholelithiasis (as described 
above), and long-term operative complications (to be described in the following 
chapters), which may be underrepresented in short-term studies The need for studies of 
the long-term effects of bariatric surgery is well-known, and efforts are being made to 
address it. 
 
1.2.7.5 Quality of Life 
Patients who have severe weight problems also have to live with the social stigma 
attached to this condition. This often leads to issues such as depression and difficulties in 
social interactions as well as lack of confidence and low self-esteem. Weight loss surgery 
will have a significant and superior impact on the quality of life of severely obese patients 
compared with traditional treatment (97). 
 
The lifestyle benefits of weight loss surgery include: Improved mobility and stamina; 
better mood and greater self-esteem; better relationships; enhanced quality of life (102); 
patients become less self-conscious; they develop a greater ability to explore social and 
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vocational activities formerly inaccessible; they benefit from increased marital 
satisfaction (102). It is important to note, however that some patients fail to achieve the 
quality of life that they think that the surgery will provide them (39). This is sometimes 
due to complications of the weight loss itself such as loose and baggy skin, with some 
patients wishing that they had never had the surgery (103,104). These issues are 
discussed further below. The importance of careful psychological assessment and pre-
operative screening cannot be understated.  
 
The Cons of bariatric surgery 
1.2.7.6 Complications and Side-effects  
1.2.7.6.1 Perioperative Mortality 
Severe complications have decreased over time; deaths generally occur in less than 1% of 
patients. The Swedish Obese Subjects study reported 5 deaths in 2,000 patients, 
corresponding to a mortality rate of 0.2% (105); however, single series and population 
studies have reported significantly higher mortality rates approaching 2% (106-108) with 
the highest figures pertaining to complex revision procedures. 
 
Low perioperative mortality rates affect the interpretation of the role of weight reduction 
per se on mortality, now demonstrated to be reduced after bariatric surgery (84-87).  
Operative mortality is strongly related to surgical volume (109) and has decreased 
dramatically with the wide adoption of laparoscopic procedures during the last 6 years. A 
comprehensive systematic review comparing short-term mortality among 5,780 patients 
with laparoscopic adjustable gastric banding (0.05%), 2,858 with vertical banded 
46 
 
gastroplasty (0.31%) and 9,258 patients with gastric bypass (0.50%) demonstrated 
significantly lower mortality rates with laparoscopic adjustable gastric banding. The most 
common causes of death are pulmonary embolism, unrecognized intra-abdominal leaks 
and myocardial infarction, although the incidence of fatal myocardial infarction is lower 
after surgical than medical treatment of obesity (106). 
 
A recent NIH funded study is arguably one of the most significant studies ever conducted 
on the safety of bariatric surgery (110).  This was the first large-scale study conducted by 
LABS (Longitudinal Assessment of Bariatric Surgery), which followed 4,776 first-time 
bariatric surgery patients for 30 days at 10 U.S. hospitals between 2005 and 2007 (3.412 
gastric bypass patients and 1,198 gastric band patients, 166 patients had other procedures 
that were not included in the final analysis). Some of the key findings were at 30 days 
post-surgery, researchers found the mortality rate among patients who underwent a Roux-
en-Y gastric bypass or laparoscopic adjustable gastric banding to be 0.3%, and a total of 
4.3% of patients had at least one major adverse outcome. Complication rates were greater 
in people with a history of clot problems, sleep apnoea and certain other medical issues. 
The study found that the risks of bariatric surgery have dropped dramatically and, 
currently, the risks are no greater than gallbladder or hip replacement surgery. The risks 
of surgery are lower than the longer-term risk of dying from heart disease, diabetes and 
other consequences of carrying  more  weight  than  a  person’s  organs  can  tolerate.  The  
findings of this research strongly reaffirm the safety of bariatric surgery and should help 
to inspire greater confidence from the general public and policymakers.  
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1.2.7.6.2 Surgical Complications 
Overall the mortality rate associated with bariatric surgery is low (0.08%-0.31%) (111). 
A recent systematic review has shown that most post-operative complications tend to 
occur after bypass surgery but the reoperation rate is highest in those undergoing gastric 
banding (111). Some complications are procedure-specific: for example adjustable gastric 
banding does not entail entering the gastrointestinal tract and does not affect bowel 
function. However, band erosion can cause pain and obstruction. Pouch enlargement and 
band slippage can result in acid reflux, and slippage can also contribute to vomiting and 
can lead to gastric ischaemia if the prolapsed stomach twists forming a volvulus.  Patients 
who undergo biliopancreatic diversion may suffer from significant reflux and also 
metabolic complications due to malabsorption (112). The former is rarely seen after 
gastric bypass because most of the stomach acid-producing cells are excluded and the 
latter does not occur either with bypass as only a short segment of small intestine is 
bypassed in relative terms to the whole length of the small intestine. 
Marginal ulcers may develop at any stage after gastric bypass surgery on the intestinal 
side of the anastamosis and may occur in up to 10% of patients. The aetiology is 
multifactorial and may be related to one or more of the following: gastric acid; tobacco; 
non-steroidal anti-inflammatory drugs; Helicobacter pylori; gastro-gastro fistula; 
anastomotic tension with or without ischemia, foreign body (suture), and large pouch size 
(113). In operations involving stapling of the GI tract, added risks (1%) from bleeding 
and leak exist and rise if the surgery is of a revisional nature.   
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Similarly, surgical approach (open versus laparoscopic) affects the types of 
complications. A recent review of gastric bypass (114) found statistically significant 
differences in numerous complications, particularly wound problems in 6.6% of open 
procedures compared with 3% in laparoscopic cases. Incisional hernias are more common 
after open surgery, whereas other complications are more common after laparoscopic 
surgery, such as small-bowel obstruction (3.1% versus 2.1%), anastomotic stenosis (4.7% 
versus 0.7%) and gastrointestinal bleeding (1.9% versus 0.6%). There were no 
differences in the number of leaks (1.2%), pulmonary emboli (< 1%) or pneumonia (0.1-
0.3%). Specific complications related to the laparoscopic gastric bypass will be discussed 
in the next Chapter.  
 
1.2.7.6.3 Cholelithiasis  
Obesity itself is a major risk factor for cholelithiasis. However, accelerated weight loss, 
which occurs after gastric bypass surgery, may result in cholelithiasis (115). One study 
reports 36% of 105 gastric bypass patients develop gallstones within 6 months (116).   
 
1.2.7.6.4 Nutritional deficiencies 
Long-term adverse effects of bariatric surgery include deficiencies of vitamins and 
minerals, especially after diversionary malabsorptive operations. Gastric-restrictive 
operations have mostly caused iron deficiency in menstruating women, due to reduced 
meat consumption; rarely excessive vomiting can cause thiamine deficiency sometimes 
leading to neuropathy (117). Gastric bypass and biliopancreatic diversion are associated 
with deficiencies of vitamin B12 (118), folate, calcium and vitamin D (119-120). Patients 
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are urged to have blood nutrient levels monitored yearly. Although not proven, it is our 
understanding that daily oral vitamin and mineral supplementation is sufficient to prevent 
the aforementioned deficiencies from occurring in bypass and band patients. The varying 
efficacy of oral vitamin B12 supplementation is partly related to patient adherence, 
although some studies have demonstrated decreased uptake after surgery (118). Bone loss 
tends to occur during the first year after gastric bypass surgery and then stabilizes with 
unchanged vitamin D levels (120).  
1.2.7.6.5 Weight-loss Failure 
The most challenging long-term complication of bariatric surgery is poor or inadequate 
weight loss. This is defined as %EBWL < 50% for gastric bypass surgery patients but a 
more accurate definition should encompass return of comorbidities. The incidence of this 
complication remains unknown, perhaps because most centres do not wish to publish 
what may be considered to be failures of surgery. One study from Canada reports weight 
regain in as many as 20% of patients 10 years after surgery (121). Regardless, 
reoperations are more difficult than primary procedures and have higher perioperative 
complication rates (122). By and large, failed gastric-restrictive procedures are, 
nevertheless, best handled by conversion to a diversionary operation. Long-term failure 
of diversionary operations requires the careful adjustment of intestinal limb lengths to 
create more malabsorption, with the risk of creating frank malnutrition. This will be 
discussed more in the next chapter. 
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1.2.7.6.6 Skin complications 
Although weight loss is one of the desired effects of bariatric surgery, unfortunately as 
this occurs post-operatively, some patients begin to suffer from progressively increasing 
loose and baggy skin (123). The consequences of this loose skin affects some patients so 
much that retrospectively they would rather not have undergone a bypass operation 
(104,103). The most common complication of this skin is in the abdominal region where 
patients develop a panniculus. They can develop sub-panicular itching, skin rashes, 
dermatitis and then more functionally, difficulty with exercise, sex and finding clothes 
that fit (103,104,123). The further drawback for these patients is that although body-
contouring surgery exists to try and correct the skin issues, this is not available for 
everyone (123). Even if funding is secured, they may be faced with multiple further 
surgeries from which they will have to recover, increased risk of wound infection and 
poor healing, and even once it has healed then there will be significant additional scarring 
(103,104,123).  
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Chapter 2 
 
 
 
2. COMPLICATIONS AFTER LAPAROSCOPIC GASTRIC BYPASS 
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2.1 Introduction and literature review 
 
Laparoscopic gastric bypass is complex surgery that can result in significant 
complications. These can occur early (within the first 24 hours of surgery), intermediate 
(within the first 48 hours) or late (more than 48 hours after surgery). Such complications 
include, but are not limited to, gastro-intestinal (GI) bleeding, anastomotic leak, 
anastomotic ulceration or fistulation, GI obstruction, deep vein thrombosis and 
pulmonary embolism, skin complications, nutritional, metabolic and neurological 
complications, cholelithiasis and rarer complications. The post operative bariatric patient 
adds an additional challenge to the physician caring for them since they often mask more 
usual symptoms and signs of the particular complications they are suffering from, and 
due to their body habitus, clinical and radiological examination can be difficult. It is 
therefore essential that a high index of suspicion is maintained at all times to save patients 
from coming to any undue harm. The more common complications post LRYGB are 
discussed below.  
 
In the early phase following gastric bypass surgery bleeding (1-2%) and leaks (1-2%) at 
any of the staple lines or anastamoses may occur and require urgent reoperation. Delay in 
the treatment of a leak may result in severe sepsis and death.  The presentation of a leak 
in the bariatric  patient  may  be  subtle  with  few  symptoms  other  than  just  feeling  ‘unwell’  
and a mild tachycardia.  Hence the bariatric surgeon must have high vigilence and a low 
threshold for re-exploration. 
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Gastric remnant distention can occur acutely or chronically and may present in the early 
postoperative period or years after surgery from obstruction of the biliopancreatic limb or 
common channel. Patients are usually in distress and have epigastric pain, nausea, and 
tachycardia. In addition to leukocytosis, patients with an obstruction distal to the second 
portion of the duodenum may have elevated liver function test results and pancreatic 
enzymes from high duodenal pressure. 
 
Marginal ulcers may develop at any stage after surgery and may occur in up to 10% of 
patients. The aetiology is multifactorial and may be related to one or more of the 
following: gastric acid; tobacco; non-steroidal anti-inflammatory drugs; Helicobacter 
pylori; gastro-gastro fistula; anastomotic tension and/or ischemia, foreign body (suture), 
and large pouch size. Patients with ulcer perforation typically experience acute, severe 
epigastric pain and present with tachycardia, fever, leukocytosis, and free air on plain 
radiographs or CT studies. 
 
Yet another specific complication related to the laparoscopic gastric bypass includes 
gastrointestinal tract obstruction.  Due to the very nature of how the gastric bypass is 
constructed, it can result in blockages from scarring at the various anastomoses or by 
loops of small intestine becoming kinked secondary to getting stuck in spaces within the 
peritoneal cavity that did not exist before the surgery. Therefore, a blockage can occur at 
the gastrojejunostomy from a postoperative stricture (1%) or food bolus obstruction.  
More distally, small bowel obstruction (SBO) may be related to internal hernia formation 
(1-2%) where small bowel becomes trapped within iatrogenic gaps in the mesentery of 
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the small bowel or transverse colon (in the case of retrocolic LRYGB). A further 
complication of the retrocolic LRYGB is Roux limb obstruction caused by narrowing 
within the transverse mesocolic defect. This tends to present earlier than internal 
herniation and is usually caused by cicatrix formation and extrinsic circumferential 
compression of the Roux limb.  Chapter 5 looks at this problem in more detail.  Other 
possible causes of small bowel obstruction in this population include intussusception; 
adhesions; port site hernias; and obstruction at the jejunojejunostomy from kinking, 
stricture, or blood clot.  
 
Interestingly, the laparoscopic approach results in a higher incidence of post-operative 
bowel obstruction.  In a review including 3464 patients, Podnos et al. (114) reported a 
higher frequency of both early and late obstructions in laparoscopic bypasses when 
compared to open cases. Similar findings were noted by two prospective trials comparing 
laparoscopic to open gastric bypasses (124,125).  However some reports suggest a similar 
incidence in laparoscopic and open cases (126,127). Nelson et al (128) compared the 
incidence of small bowel obstruction between 326 laparoscopic and 458 open gastric 
bypasses and found that the difference was not statistically significant. One reason 
attributed to the higher incidence of obstruction with the laparoscopic approach is 
because very few adhesions are formed allowing small bowel loops freedom to move and 
become  ‘stuck’  in  spaces  that  did  not  exist  before  the  surgical  ‘re-organisation’  that  
occurs with the gastric bypass. 
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Internal hernias after gastric bypass are an important cause of bowel obstruction and a 
previous review article estimates mean time to presentation at nine months 
postoperatively but this is likely to be an underestimation because of the limited duration 
of follow-up (51). The observed weight loss in the time period between initial operation 
and internal hernia development certainly as weight to the hypothesis of reduced intra-
peritoneal fat leading to larger mesenteric defects (129) and thus greater herniation risk. 
Paroz et al (130) have also noted a mean loss of 14.5 BMI units between primary 
operation and internal hernia presentation.  
 
The reported literature documents significant variation between studies in regards to 
hernia location. Garza et al (131) reported transverse colon hernias as the most common 
in their series. Interestingly, they did not encounter any entero-enterostomy hernias which 
comprise the second largest group in our series. Comeau et al (132) and Carmody et al 
(133)  reported  Petersen’s  hernias  as  the  most  common  site,  which comprised only 7% in 
our population.  Paroz et al (130) and Eckhauser et al (134) reported entero-enterostomy 
as the most common location. In a review article, Ianelli et al (51) found transverse 
mesocolon as the most common site of herniation.  Similarly, Higa et al (135), in their 
review of 2000 consecutive gastric bypass patients, found transverse mesocolon as the 
most common location. This is in agreement with previous reports though some studies 
put  the  incidence  of  Peterson’s  hernias  above enteroenterostomy hernias (136). The 
reasons underlying the observed differences are not well known as an antecolic Roux 
limb by definition obviates the need to create a window in the transverse mesocolon and 
this in turn eliminates this site as a potential area for herniation. This has been noted 
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previously (126, 137, 138, 132) and is also the reason why some surgeons have switched 
from the retrocolic to the antecolic route. However, others favour the reduced tension on 
the gastrojejunostomy with retrocolic Roux positioning.  
 
Despite what is known, there remain many unanswered questions – who gets internal 
hernias, when do they occur, what causes some to be symptomatic, some deadly and 
some remain subclinical, and of course what can the surgeon do to minimise 
complications related to internal hernias? What is perhaps most interesting to note is that 
internal hernias can potentially also occur in other branches of gastrointestinal surgery 
where there is division of the mesentery.  This includes colorectal surgery, hepatic and 
oesophagogastric resectional surgery necessitating a roux-en y type reconstruction (139).  
Perhaps the reason why internal hernias have become more commonly seen in gastric 
bypass for weight loss is because firstly, nearly all such surgery is now performed using 
the  laparoscopic  approach  (resulting  in  far  fewer  adhesions  that  would  normally  ‘fix’  
bowel loops) and secondly, the weight loss subsequent to surgery leads to mesentery 
thinning (loss of fat from the mesentery) making intraperitoneal gaps and spaces appear 
where previously there were none.  
 
2.2 Conclusions of literature search 
 
Obesity has reached epidemic proportions in the developed world. RYGB offers an 
efficacious and reliable method of weight loss. Over the last decade, the number of 
bariatric procedures performed each year has grown exponentially. It is inevitable that 
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general surgeons will encounter post-operative complications with higher frequency due 
to increased numbers of index surgeries performed. In depth knowledge of post-bypass 
anatomy and careful interpretation of imaging studies is essential to prompt diagnosis and 
treatment of this group of patients.  
 
Since the time of open gastric bypass surgery, surgeons have been noting the incidence of 
complications and these have been focussed mainly on wound problems and immediately 
life threatening complications of bleeding and anastomotic leaks. The laparoscopic era 
has shifted the focus away from wound problems towards intestinal obstruction which is 
firstly,  more common than bleeds or leaks and, secondly, seemingly occurs more 
frequently  using the laparoscopic approach. In particular, internal hernias, though 
described in the surgical literature previously, have hitherto been an uncommon finding 
for the average gastrointestinal surgeon. There is a dearth of evidence documenting this 
complication with very few large patient series with long follow-up. Moreover the causes 
of intestinal obstruction after LRYGB, their incidence, detection and potential technique 
for to reduce their occurrence remains unanswered.    
 
2.3 Outline of the thesis 
 
The work presented in this thesis attempts to improve our understanding of the causes of 
SBO after LRYGB.  It focuses on the two commonest causes of SBO complication – 
internal hernias and roux limb obstruction after LRYGB.  I then look at intra-operative 
ways of minimising the incidence of internal hernias in particular. 
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In the next chapter, I will present a detailed analysis of the causes of SBO following 
LRYGB. The chapter will discuss the experience at a high volume center with the 
management of post-LRYGBP intestinal obstruction, with special focus toward clinical 
presentation, aetiology, and the diagnostic clues used. In chapter 4, a detailed analysis is 
made of how best to image symptomatic IH after LRYGB. Chapter 5 looks at another 
cause of SBO after LRYGB, namely Roux limb constriction at the transverse mesocolic 
rent. The aim of that study is to examine the incidence of Roux limb compression with 
particular attention to the timing of presentation and associated weight loss. A Kaplan-
Meier time to event analysis is performed to compare Roux limb obstruction with internal 
hernia. Chapter 6 focuses on different surgical techniques that may be used by the 
surgeon to try and reduce the incidence of internal hernias. Chapter 7 utilises root cause 
analysis techniques for the first time in the field of bariatric surgery to analyze the 
operative videos of 3 groups: an IH group, a Roux compression group, and a control 
group. All errors were categorized and an assessment made to see if any particular 
intraoperative errors can be identified that predispose to IH or roux limb compression. 
Chapter 8 looks at a different surgical technique of performing gastric bypass (antecolic, 
non mesenteric division and non closure of IH spaces) and analyses its effects on IH 
incidence. 
 
2.4 Aims of the thesis 
 
(i) To assess the aetiology and incidence of small bowel obstruction after laparoscopic 
Roux-en-Y gastric bypass 
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(ii) To understand the common radiological findings in symptomatic internal hernias 
(iii) To analyse the condition of Roux limb obstruction secondary to constriction at the 
transverse mesocolon window 
(iv) To assess the impact of surgical technique on the incidence of internal hernia in 
particular:  
(a) the method of closing mesenteric defects and antecolic Roux limb placement,  
(b) the use of bioabsorbable glycolide copolymer staple-line reinforcement and 
internal hernia incidence 
(v) To perform a root cause analysis of bowel obstruction after LRYGB using 
Observational Clinical Human Reliability Assessment (OCHRA) 
(vi) To investigate an alternative surgical technique, namely antecolic antegastric, 
LRYGB without mesenteric division, in an attempt to reduce IH incidence. 
 
2.5 Thesis Methodology 
Chapters 3, 4 and 5 provide descriptive statistics of prospectively collected but 
retrospectively analysed surgical data. This surgical data was obtained through physically 
reviewing the medical records of all patients undergoing surgery to relieve intestinal 
obstruction after LRYGBP between May 24, 2001, and December 1, 2006 at the Strong 
Health Bariatric Center, Highland Hospital. This set of patients was identified through 
interrogating  the  hospital’s  internal  bariatric  surgery  electronic  database  over the 
specified time period using the specific procedure codes used for gastric bypass and 
reoperation after gastric bypass. This yielded over 2300 entries. The medical records 
(including operating room records) of these were scrutinised to assess those patients that 
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had a reoperation for bowel obstruction specifically (other causes for reoperation 
included body contouring surgery, reoperating for bleeding, leaks, and abdominal wall 
hernia repairs). Patients with gastrojejunal strictures were treated endoscopically and 
were not included in this series. Also, intestinal obstructions occurring after open 
bypasses were excluded. This yielded a subset of 111 patients whose notes were 
painstakingly reviewed and factual data extracted to feed a purpose built spreadsheet (see 
Appendix 1). A standardized protocol was used for data extraction. Records were 
reviewed to note patients’  demographic  data, operation date and type of LRYGB, time to 
representation with SBO, presenting symptoms, imaging studies used, causes identified at 
exploration, and type of procedure performed (laparoscopic vs open). Operative notes 
were analyzed in detail to assess the technique used to perform gastric bypass including 
Roux limb orientation, the use of adjuncts such as staple line reinforcement and the type 
of sutures and their placement in the closure of IH defects. For data capturing in Chapter 
7, individual videos of operations were reviewed by two assessors. 
 
As particular chapters focus on individual causes of small bowel obstruction, and in some 
cases its management, the study sample cohort size changes appropriately. This, and the 
statistical analysis for each individual study is described in the chapter’s  methodology  
section. 
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Chapter 3 
 
 
 
3. AETIOLOGY OF SMALL BOWEL OBSTRUCTION AFTER 
LAPAROSCOPIC GASTRIC BYPASS 
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3.1 Introduction 
The proven efficacy of laparoscopic gastric bypass has resulted in increased popularity of 
this procedure and is currently the most common bariatric procedure performed 
worldwide (140). Compared to its open counterpart, the laparoscopic approach results in 
a lower rate of wound complications, incisional hernias and a shorter hospital stay. 
However, LRYGB has been reported to have a higher incidence of small bowel 
obstruction (114,124-125). In this chapter, a detailed study of the causes of SBO after 
LRYGB is presented. 
 
3.2 Aim 
To examine the clinical presentation and causes of intestinal obstruction after LRYGB 
 
3.3 Methods 
3.3.1 Patients 
All patients undergoing surgeries to relieve intestinal obstruction after LRYGB were 
included between Jun 01 and Sep 06.  Intestinal obstructions occurring after open 
bypasses were excluded. 
3.3.2 Setting 
Strong Health Bariatric Center, Highland Hospital 
3.3.3 Procedure 
During the study period, 2325 LRYGB were performed using a standardised technique. 
Procedures were performed using five 12 mm trocars. Access to peritoneal cavity was 
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gained using trocar with visualization at the left upper quadrant or umbilical region. The 
remainder of the trocars were placed over the right upper quadrant, subxiphoid and left 
flank regions under direct laparoscopic visualization. Jejunum was divided about 30 cm 
from the ligament of Treitz using a linear stapler. A side to side enteroenterostomy was 
accomplished using linear stapler 150 cm distal to the point of Jejunal division. The 
resultant enterotomies were closed using 3-0  Vicryl  sutures.  “Anti-obstruction sutures”  as  
described by Brolin (141) were placed to prevent angulation at enteroenterostomy. A 20-
30 ml stomach pouch was created by sequential firing of linear stapler. If a retrocolic 
technique was used, the Roux limb was passed through a window in transverse 
mesocolon into the lesser sac and mesenteric defects at enteroenterostomy, mesocolon 
and  Petersen’s  sites  were  closed  using  non-absorbable sutures. In cases where antecolic 
technique was used, the Roux limb was passed through a small opening created in the 
omentum. Mesenteric closures were not undertaken in antecolic cases. Side-to-side 
gastrojejunostomy was performed using a linear stapler in all cases and a double-layered, 
hand sown closure was used for resultant enterotomies. 
3.3.4 Assessment 
A retrospective review was performed between Jun 01 and Sep 06.  Patients medical 
notes were reviewed to record presenting symptoms, aetiologies identified at exploration 
and type of procedure performed (laparoscopic versus open).  
3.3.5 Statistical analysis 
The clinical presentation and causes are tabulated. Chi-square test was used. Significance 
level was set at p value of <0.05. 
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3.4 Results 
3.4.1 Patients characteristic 
Over the study period, 111 procedures were carried out with a pre-operative diagnosis of 
intestinal obstruction out of a total of 2325 laparoscopic gastric bypasses performed. No 
evidence of intestinal obstruction was found in 9 cases and these procedures were 
labelled as negative explorations. In the remaining 102 cases, intestinal obstruction was 
confirmed intra-operatively, yielding an overall incidence of 4.38%.  The 102 cases 
presenting with SBO were mainly women  (94 women and 8 men) which mirrors the 
population of patients undergoing LRYGB.  Mean age was 44, pre-LRYGB BMI was 50 
kg/m2 and mean BMI at the time of reoperation was 34 kg/m2.   
 
3.4.2 Clinical picture 
Most of the patients in our series presented with abdominal pain, which was documented 
in 91 (82%) patients. Other common presenting symptoms included nausea in 54 patients 
(48.6%), vomiting in 52 patients (46.8%), bloating in 3 patients (2.7%) and dysphagia in 
one patient (0.9%). Thirty one (27.9%) patients were noted to present with all three of the 
above motioned symptoms.  
 
3.4.3 Onset of presentation 
The interval between LRYGB and intervention for bowel obstruction varied greatly 
ranging from 3 to 1215 days with a mean of 313 days. Figure 2.1 presents the distribution 
of surgical explorations over time. We witnessed a steady decline in the number of 
explorations performed for intestinal obstruction with increasing interval after LRYGB. 
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Figure 2.1 Distribution of small-bowel obstruction after gastric bypass 
 
3.4.4 Causes of bowel obstruction 
Out of a 102 cases of bowel obstruction confirmed upon exploration, the most common 
cause in our group was internal hernias seen in 55 patients (53.9%). The second most 
common cause of intestinal obstruction was scar-induced stricture of the Roux limb as it 
passed through the mesocolic window encountered in 21 patients (20.5%). Adhesion 
induced obstructions were encountered in 14 patients (13.7%). Remaining causes of small 
bowel obstructions were angulation at enteroenterostomy observed in 7 patients (6.8%), 2 
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patients (1.9%) at port site and at enteroenterostomy level and one patient (1%) of 
abscess induced obstruction.  
Out of a total of 111 explorations, laparoscopic technique was used in 92 patients (83%) 
and conversion to open procedures was required in only 19 patients (17%). Pathology 
necessitating bowel resection was encountered in 2 cases. There were no deaths in this 
series. 
 
3.4.5 Discussion 
This is one of the largest series of bowel obstructions post LRYGB that has been studied.  
Over the study period, 111 procedures were done with a pre-operative diagnosis of 
intestinal obstruction out of a total of 2325 laparoscopic gastric bypasses performed. Nine 
explorations were considered negative as no evidence of intestinal obstruction was found 
intra-operatively.  In the remaining 102 cases, intestinal obstruction was confirmed intra-
operatively; an overall incidence of 4.38%.  The reported incidence of small bowel 
obstruction after LRYGB ranges from 1.5 to 5% (126,142,136,143,137). 
 
 
 
Most of the patients in our series presented with abdominal pain, which was documented 
in 82% of patients. We encountered both acute abdominal discomfort and chronic, 
intermittent presentations. Other common presenting symptoms included nausea and 
vomiting. Nausea and vomiting, the dominant symptoms of small bowel obstruction 
(144), were seen in less than half of our patients (48.6% and 46.8% respectively). Due to 
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the small size of gastric pouch, voluminous vomiting is rarely encountered in this patient 
population and most of our patients reported small amounts of clear emesis or dry 
heaving. Bilious vomiting in a gastric bypass patient indicates obstruction at or beyond 
the level of enteroenterostomy until proven otherwise and warrants an expeditious 
workup and intervention. One notable exception is Gastro-gastric fistula, which may 
manifest as abdominal pain and bilious vomiting; however, this is a rare complication 
with a completely isolated gastric pouch (145). 
 
The most common cause of obstruction in our group was internal hernias seen in 53.9 % 
cases. Interestingly, internal hernias are reported to be a rare complication after open 
gastric bypasses (135).  The second most common cause of intestinal obstruction was 
scar induced stricture of the Roux limb as it passed through the mesocolic window, 
encountered in 20.5% cases and further analysis of this is presented in Chapter 4. 
Surprisingly, adhesion induced obstructions which usually comprise the leading cause of 
post-op bowel obstruction in open surgeries comprised only a small fraction of patients 
(13.7%).  
 
Reported literature about laparoscopic management of post LRYGB intestinal 
obstructions indicates a high rate of conversion to open when intestinal obstructions were 
managed laparoscopically. Champion et al (126) reported a conversion rate in cases of 
bowel obstruction of 2/13 while Nguyen et al (142) reported a rate of 2/8. Papasavas et al 
(138) were able to manage 14 out 15 obstructions laparoscopically. We were able to 
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successfully relieve obstruction laparoscopically in the majority of the cases and 
conversion to open procedures was required in only 19 cases.  
 
Small bowel obstruction in bypass population is frequently complicated by bowel 
ischemia and often involves bowel resection. Hwang et al (136) required bowel resection 
in 30/55 cases and Capella et al. reported resection in 3/68 (146). Frezza et al (147) 
described resection in 14% cases. In our series, only two patients required bowel 
resection. We follow a policy of maintaining a high index of suspicion and a low 
threshold for laparoscopic exploration which, perhaps, resulted in the lower resection 
rate. The drawback of this policy is potential for negative explorations which were 
encountered in 9/111 cases in our series. However, the risks associated with delayed 
intervention outweigh the risk of a negative exploration. 
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Chapter 4 
 
 
4. RADIOLOGICAL FINDINGS IN SYMPTOMATIC INTERNAL HERNIAS 
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4.1 Introduction 
Clinically, internal hernias can be asymptomatic or cause significant discomfort ranging 
from constant vague epigastric pain to intermittent colicky periumbilical pain.   Patients 
with symptomatic internal hernias often present acutely to the emergency department 
with clinical features suggestive of bowel obstruction – intolerance of oral intake, nausea, 
vomiting and abdominal pain. Symptom severity relates to the duration and reducibility 
of the hernia and the presence or absence of incarceration and strangulation. The 
differential diagnosis includes anastomotic stricture, Roux limb constriction (in cases of 
retrocolic Roux limb placement), adhesions, cholelithiasis, and marginal ulceration.  
 
In order to narrow the diagnosis, diagnostic imaging techniques need to be used. These 
include plain abdominal X-ray, ultrasound, Upper Gastro-Intestinal UGI series and 
Computed Tomography CT scan. Because of the propensity of these hernias to 
spontaneously reduce, patients are best imaged when they are symptomatic.  However 
delayed treatment can have catastrophic consequences and patients with worrisome 
findings on presentation should be considered for immediate surgical exploration without 
radiological work-up.   
 
4.2 Aims 
The objective of this study was to determine (i) the most accurate imaging modality to 
diagnose internal hernias post LRYGB and (ii) radiological signs suggestive of internal 
herniation. 
 
71 
 
4.3 Methods 
4.3.1 Patients 
We performed a retrospective review of the notes of all patients (2578) undergoing 
LRYGB and identified those who developed symptomatic internal hernia requiring 
operative intervention between Jan 1, 2000 and September 15, 2006. During the 
postoperative observation period, 58 patients presented with abdominal pain, nausea, 
vomiting, or a combination of these symptoms and were found at relaparoscopy to have 
an IH; thus, the overall IH rate in the series was 2.2%.  
 
4.3.2 Setting 
Strong Health Bariatric Center, Highland Hospital  
4.3.3 Details of radiological procedures 
Imaging modalities were (i) plain X-ray; (ii) upper GI series with orally administered 
water-soluble contrast medium (diatrizoate meglumine and sodium [Gastroview]; 
Mallinckrodt Medical, St Louis, Mo); (iii) Helical CT scanner (Philips Brilliance 16P, 
Philips, Cleveland, Ohio) with section thickness of 5mm whereas the scans were obtained 
with intravenous 100 mL of 64% iodinated non-ionic contrast medium (ioversol [Optiray 
300]; Mallinckrodt Medical) administered at a rate of 2–3 mL/sec with a power injector 
(OptiVantage DH, Liebel-Flarsheim,Mallinckrodt Medical). Oral contrast medium was 
also used routinely.  
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4.3.4 Assessment 
A retrospective review of the medical records of the 58 patients with an IH was 
conducted and the following information noted: the types of radiological tests performed 
on presentation and their results were recorded; all radiology reports were accessed using 
an electronic radiology results database (Stentor) and the final verified radiologist report 
used for this study. A second analysis was performed to see if any clear radiological 
patterns emerged suggesting (i) presence of internal herniation and (ii) location of 
internal herniation. 
 
4.4 Results 
Fifty eight symptomatic internal hernias were recorded, of which 56/58 (97%) underwent 
radiological investigation; 2/58 went directly to surgery. Figure 3.1 demonstrates the 
types of imaging tests performed in the cohort. A number of patients underwent more 
than 1 imaging tests. Table 3.1 summarizes the results of the imaging tests performed. 
For the purposes of our analysis, a positive finding of an internal hernia is defined as any 
abnormal radiological finding suggestive of intestinal obstruction since direct 
identification of an internal hernia defect itself is difficult. 
 
 
 
 
 
 
 
 2578 patients 
58 internal 
hernias 
56 - 
radiological 
imaging 
41 - plain 
abdominal film 
37 - CT 
26 - Upper GI 
contrast study 
10 - CT + 
upper GI 
8 - Ultrasound 
2 - surgery 
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Figure 3.1   Diagnostic imaging tests performed in 58 symptomatic internal hernias. 
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Table 3.1 Type of diagnostic imaging modality performed and results.   
Radiological test performed N Positive finding suggestive of 
internal hernia (%) 
Abdominal x-ray  41 19 (46%) 
CT  37 34 (92%) 
Upper GI contrast  26 17 (65%) 
CT + Upper GI contrast  10 10 (100%) 
Ultrasound abdomen  8 0 (0%) 
 
 
None of the 8 abdominal ultrasound scans diagnosed internal hernias. The main 
indication for ordering abdominal sonogram was to exclude acute gallbladder pathology. 
Thirty four out of 37 (92%) CT scans (with oral contrast) performed were reported 
positive for internal hernia. The CT scan reports were further analysed and their findings 
summarized. Four recurring findings suggestive of internal hernia were identified: (i) 
dilated small bowel, (ii) distended gastric remnant, (iii) excess small bowel loops in the 
lesser sac, and (iv) thickened fluid filled small bowel. Of the 3 internal hernias (2 
transverse mesocolic and 1 entero-enterostomy) that were negative on CT, two underwent 
upper GI series which had positive findings suggestive of internal hernia; the third patient 
underwent laparoscopy as the CT scan although negative for internal hernia demonstrated 
a thickened appendix suggestive of appendicitis. At laparoscopy, an entero-enterostomy 
internal hernia was found. Seventeen out of 26 (65%) of upper GI contrast series were 
reported positive for internal hernia. The upper GI radiology reports identified 4 recurring 
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findings suggestive of internal hernia: (i) dilated fluid filled small bowel loops, (ii) 
redundant Roux limb in lesser sac, (iii) preponderance of bowel loops in the left upper 
quadrant, and (iv) slow emptying of contrast with prolonged transit times, especially on 
delayed films. Of the 9 upper GI series that were reported negative, CT scans were 
performed in 4 of these and were reported positive for internal hernia.  The results of this 
study also demonstrate that the 10 patients who underwent both CT and Upper GI series 
had correctly diagnosed internal hernia in all cases. In our secondary analysis, we could 
not find any evidence to suggest an association between particular radiographic findings 
and location of internal hernia. 
 
4.5 Discussion 
Internal hernias are a known complication after LRYGB with an incidence of around 2% 
in the present series which is in keeping with a recent review of 26 studies (51).  It is 
important to identify them so that timely treatment may be instituted.  Patients often 
present with non-specific symptoms with a diverse differential diagnosis. Hence it is 
useful to know which diagnostic imaging test offers the most likelihood of correctly 
identifying IH.  The results of this study indicate that CT scanning with intravenous and 
oral contrast correctly identified IH in 92% of cases. In equivocal cases, the addition of 
UGI study increases the diagnostic rate to 100%. Regardless of these findings, it is 
important not to delay surgical exploration in sick patients, even in the absence of a 
positive finding on imaging, in the hope that some less threatening diagnosis is 
responsible  for  the  patient’s  condition.  This practice may lead to potentially devastating 
bowel strangulation and sepsis. 
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Previous reports have been published regarding the range of radiological findings seen 
after LRYGB (50, 148-160). Performing diagnostic imaging in the morbidly obese is 
associated with certain limitations. There are two main modalities used to aid diagnosis in 
post-LRYGB patients: Computed tomography (CT) and UGI series. CT in postoperative 
morbidly obese patients may be difficult or impossible because of excessive weight and 
girth. UGI studies have the advantage that they can be performed with the patient 
standing and thus there is no weight restriction.  Technical problems do occur and include 
difficulty in positioning of patients for optimal radiographs, inability to place the image 
intensifier over the patient, extreme difficulty during fluoroscopy in depicting 
intraabdominal structures, and suboptimal radiographs caused by markedly scattered 
radiation (154).   On the other hand, spiral CT scanning technology has resulted in shorter 
scanning time and improved image quality resulting in a detailed view of the anatomy 
after LRYGB, with all important structures clearly depicted (161). These factors have 
contributed to the increased use of this modality for the detection of complications after 
gastric bypass surgery that might not be readily identified with a conventional UGI series.  
CT also offers the added advantage of providing guidance for interventional procedures 
such as aspiration and drainage of fluid collections.  CT scanning is, however, more 
expensive and exposes the patient to greater radiation than UGI series. 
 
With regards to IH diagnosis post LRYGB, our UGI diagnostic rate of 65% is similar to 
that reported previously by Blachar et al who noted 6 of 9 internal hernias correctly 
diagnosed on UGI in their series of 15 patients presenting with small bowel obstruction 
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(162).  They were able to ascertain from the radiographs that the herniated bowel was 
usually the Roux limb or the biliopancreatic limb. Our series demonstrates a high 
diagnostic rate (92%) for IH using CT scan. Both Blachar et al (162) and Yu et al (160) 
found CT to only correctly diagnose 66% of IH, but their numbers of IH patients that 
underwent CT were very low, 3 in each study. Interestingly it was noted that the two 
positive CTs for IH were in the absence of clinical features of bowel obstruction (160).  
Others have demonstrated that CT scanning allows an accurate diagnosis of IH after liver 
transplantation which also necessitates a Roux-en-Y reconstruction (163-165). 
 
Although it is difficult to distinguish small-bowel obstruction caused by adhesions from 
that caused by internal hernia on the basis of findings from CT, UGI series, or both; there 
are certain repeated radiological findings in the series of 56 IH that underwent 
preoperative diagnostic imaging.  In particular the finding of clustered small bowel loops 
in the left upper quadrant seems to be a fairly specific finding for IH in the study as well 
as that of Blachar et al who noted this specific finding was present in 89% of patients 
with IH (162).   
 
Whilst we were unable to document any association between a particular radiological 
sign  and  type  of  IH  (transverse  mesocolic  vs.  enteroenterostomy  vs.  Peterson’s),  others  
have found that the appearance of internal hernias, particularly on CT, depends on their 
location. Clustering of dilated small-bowel loops and crowding and congestion of the 
mesenteric vessels are generic features seen in all IH cases (149). But in cases of 
herniation through the transverse mesocolon, the herniated cluster of bowel is located 
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posterior relative to the stomach (in the lesser sac) and may exert mass effect on its 
posterior wall. In herniations through the small-bowel mesentery, the clustered bowel is 
pressed against the abdominal wall with no overlying omental fat, causing central 
displacement of the colon (149). The same investigators also noted that the Peterson type 
hernia is difficult to diagnose because it has neither a confining sac nor a characteristic 
location, and the only clues to its presence may be engorgement and crowding of the 
mesenteric vessels and evidence of small bowel obstruction. 
 
In this study, 41/56 IH patients had a plain abdominal X-ray and 8/56 patients underwent 
abdominal sonogram. Emergency department physicians requested the plain X-rays. Just 
under half of these were reported as having signs consistent with IH. In fact there is no 
radiological sign for IH on plain abdominal radiograph, but the radiologists reports took 
into account the context in which the X-rays were taken, namely, in post LRYGB patients 
with clinical features of subacute bowel obstruction and this, in turn, provided an 
important clue to the underlying diagnosis. Unsurprisingly, none of the sonograms were 
positive for IH, the reason being they were requested to rule out gallbladder pathology 
(acute cholecystitis) post LRYGB. 
 
This study has some important limitations.  The primary limitation of the study is that it is 
retrospective, and results therefore are compromised by the factors that limit all 
retrospective studies.  In addition, the results are affected by a population bias in that only 
patients with suspected IH underwent diagnostic imaging. Currently, we do not have 
imaging data on post-LRYGB patients who are asymptomatic or only mildly 
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symptomatic and yet have IH. Hence, I am unable to calculate sensitivity, specificity, 
positive and negative predictive values for CT and UGI as diagnostic tests for IH.  
Another limitation is that regarding the standardization of administration time of oral 
contrast agents prior to imaging. Unfortunately, these data were not noted and it may 
influence the diagnostic rate for IH, particularly in the context of CT scanning.  However, 
tolerance of per oral intake in this group if acutely presenting with IH patients will always 
be limited.   
 
Upper gastrointestinal radiography and CT are useful in depicting the normal anatomy 
after gastric bypass surgery and are complementary in detecting complications after 
surgery, thus allowing early diagnosis and treatment. Internal hernias present a diagnostic 
challenge. Preoperative CT scanning indicated the presence of IH in 92% of cases in the 
current study, the diagnostic rate rising to 100% when CT is combined with UGI 
examination. Regardless, patients with worrisome findings on presentation should be 
considered for immediate surgical exploration without radiological work-up. 
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Chapter 5 
 
 
5. ROUX LIMB OBSTRUCTION SECONDARY TO CONSTRICTION AT 
TRANSVERSE MESOCOLON WINDOW 
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5.1 Introduction 
Small bowel obstruction is a recognised complication of laparoscopic Roux-en-Y gastric 
bypass (LRYGB) occurring in up to 4.3% of patients undergoing surgery (Chapter 2). 
Causes include internal herniation, postoperative adhesive bands, anastomotic strictures 
and incarcerated incisional hernias.   In retrocolic LRYGB, partial small bowel 
obstruction can also occur as a result of circumferential extrinsic compression of the 
retrocolic Roux limb as it traverses the transverse mesocolon rent from thickened cicatrix 
formation in this area. Patients can present with acute symptoms of vomiting and, 
occasionally, with less acute symptoms of upper abdominal discomfort and intolerance of 
any oral intake other than liquids.   Upper GI contrast study and CT scan can confirm the 
diagnosis, however, in some cases the diagnosis is only clear at laparoscopy. In most 
cases the Roux limb can be mobilised laparoscopically to resolve the compression caused 
by cicatrisation and thus relieve the obstruction. Previous studies have noted the 
incidence of retrocolic Roux limb compression to be 0.4-1.2% (126,142,136,138, 166, 
167) although no definite evidence has been forthcoming regarding the timing of this 
complication post weight loss surgery.  
 
5.2 Aim 
The aim of this study is to examine trends in Roux limb constriction at the transverse 
mesocolic window after retrocolic LRYGB.   
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5.3 Methods 
5.3.1 Patients 
Between Jan 1, 2000 and September 15, 2006, 2215 patients underwent retrocolic 
LRYGB. During the observation period, 20 patients presented postoperatively with 
abdominal pain, nausea, vomiting, or a combination of these symptoms. They were all 
investigated with an upper GI contrast study and were found at re-laparoscopy to have 
Roux limb compression at the transverse mesocolic defect. 
 
5.3.2 Setting 
Strong Health Bariatric Center, Highland Hospital  
5.3.3 Surgical technique 
The operative technique used for the retrocolic LRYGB begins with CO2 insufflation.  
The small bowel is divided approximately 30 cm from the ligament of Treitz with an 
ETS-45 stapler (Ethicon Endo-Surgery Inc, Cincinnati, OH). Distal bowel is measured 
150 cm and this will be the length of the Roux limb. A side-to-side functional end-to-side 
enteroenterostomy is performed between the afferent limb to the 150 cm mark on the 
Roux limb. A transverse application of the ETS-45 stapler with the 3.5 mm cartridge is 
followed by multiple vertical applications of the same type of stapler to create a 
completely isolated proximal gastric pouch approximately 15 to 30 cc in volume. The 
harmonic scalpel is used to create a longitudinal window in an avascular area in the 
transverse mesocolon just lateral of the middle colic vessels. The stapled end of the Roux 
limb is passed across the aforementioned rent retrocolic retrogastric and a side-to-side 
functional end-to-end gastrojejunostomy is performed. We used a continuous 3/0 silk 
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suture to secure the Roux limb to the transverse mesocolon to prevent Roux limb slippage 
and transverse mesocolic hernias. In September 2003, we switched from using a 
continuous suture to using 4 x 3/0 interrupted silk stitches to secure the Roux limb to the 
transverse mesocolon in an attempt to reduce our Roux obstruction rate, hoping that 
interrupted sutures will be less of a stimulus for cicatrix formation. 
 
Our operative technique for treating Roux limb compression at the transverse mesocolon 
rent comprises establishing pneumoperitoneum. By elevating the transverse colon 
cephalad and toward the anterior abdominal wall, the transverse mesocolon defect is 
exposed. Previously placed stitches anchoring the Roux limb circumferentially to 
mesocolon are cut and the transverse mesocolic space is gently stretched to break free 
cicatrix, occasionally the harmonic scalpel is required to maintain haemostasis. At this 
stage it is quite common to find the Roux limb circumferentially indented where it was 
being externally compressed by cicatrix. A further 3 to 4 stitches are then reinserted 
between Roux limb and mesocolon to prevent occurrence of transverse mesocolic internal 
hernia. 
 
5.3.4 Assessment 
A retrospective review of the medical records of the 20 patients with Roux limb 
obstruction was  performed  and  the  following  information  recorded:  the  patient’s  age,  sex,  
and preoperative BMI; the mesocolic window closure technique (interrupted vs 
continuous suture); the upper GI contrast study result; the amount of postoperative weight 
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loss (percentage of excess body weight lost [%EBWL]); and the postoperative time to 
presentation with Roux limb obstruction. 
 
5.3.5 Statistical analysis 
The information obtained on patients with Roux limb obstruction in whom the mesocolic 
window was closed with continuous suturing (657 of the 2215) was compared with data 
on patients with interrupted closure of the same (1558 of the 2215). Chi square test was 
used to test the hypothesis that a difference in suturing technique affects Roux limb 
obstruction incidence. A second follow-up analysis was used to compare the Roux 
obstruction group of patients with a second series of patients from the same population of 
2215 LRYGB patients who developed internal hernias to evaluate time to event 
difference in the two groups. The Kaplan-Meier method was used for this follow-up 
analysis and the groups were compared with the log-rank test.  A p value less than or 
equal to 0.05 was considered to represent a significant difference.  
 
5.4 Results 
The overall incidence of Roux limb obstruction in our series was 0.9%. The mean follow-
up time in the entire series of 2215 patients who underwent LRYGB was 36 months. The 
mean time until postoperative presentation with abdominal symptoms in the 20 patients 
found to have Roux limb compression was about 48 days after LRYGB.  These patients 
presented acutely to the Emergency Department or through an urgent outpatient 
consultation with symptoms of abdominal pain, intolerance of oral intake, nausea and 
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vomiting. All patients were managed laparoscopically by releasing the constricted Roux 
limb by the technique described above; none of the cases required any bowel resection.  
 
Table 4.1 shows demographic, operative, and follow-up data on the 20 patients in whom 
Roux limb obstruction occurred after LRYGB.  In 18 of the 20 patients, upper GI contrast 
study confirmed the diagnosis by demonstrating dilated small bowel in the lesser sac 
and/or a stenosis at the transverse mesocolic defect (Figure 4.1).  
 
Table 4.1 Demographic, operative, and follow-up data in patients with postoperative 
Roux limb obstruction, according to mesocolic window closure using continuous suture 
or interrupted suture  
  
Patients with Roux limb obstruction 
(n = 20) 
 Continuous 
suture closure 
(n = 11) 
Interrupted 
suture closure 
(n=11) 
p value 
 
Mean age, years (range) 
 
42 (25-55) 
 
42 (25-60) 
 
Sex: M/F 1/10 1/8  
Mean preoperative BMI 47 48  
Mean no. of postoperative days 
to presentation with Roux 
obstruction (range) 
53 (27-105) 42 (24-114) 0.17 
Average % excess body weight 
loss (%EBWL) at presentation 
with Roux obstruction 
29 28 0.22 
Incidence 
(%) 
11/657 
1.7% 
9/1558 
0.6% 
0.02 
Upper GI contrast study 
diagnostic 
Yes (10/11),  Yes (9/9)  
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Figure 4.1 Upper GI contrast study x-ray demonstrating compression of Roux limb as it 
goes across the transverse mesocolic rent 
 
 In the other two cases, the radiologist’s report was equivocal but the surgeon felt Roux 
limb compression was present in one case; previous contrast from a CT scan made the 
upper GI series images in the other case difficult to interpret. The Roux limb obstruction 
rate among 657 patients who had a continuous closure of the mesocolic defect was 1.7%, 
whereas that among the 1558 patients who had interrupted closure was 0.6%; this 
difference was significant (p = 0.02). Among the 20 patients in whom Roux obstruction 
occurred, the baseline patient demographics, amount of weight loss, and time to 
presentation were similar in the continuous suture-closure and the interrupted suture-
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closure groups. There was, however, a difference in mean follow-up time in the 2 groups 
(48 months for continuous closure vs. 24 months in the interrupted group). 
 
Figure 4.2 shows time to reoperation when comparing 20 patients in whom bowel 
obstruction occurred from Roux obstruction compared with a series of 58 internal hernia 
patients from the same population of 2215 LRYGB patients. Roux limb obstruction 
patients present for surgery significantly earlier than those patients who have internal 
hernias (p < 0.0001 for difference in time to presentation).  
 
Figure 4.2   Time to reoperation for Roux limb obstruction or internal hernia: Kaplan-
Meier estimates of survival function 
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5.5 Discussion 
Narrowing at the transverse mesocolon rent is an uncommon complication after 
laparoscopic (retrocolic) Roux-en-Y gastric bypass. Our 0.9% incidence in 2215 patients 
is  consistent  with  Higa  and  Boone’s  rate  of  1%  in  their series of 1040 patients (126).   
Our data report the incidence of this complication in one of the largest documented series 
of retrocolic LRYGBs, which benefits from an extensive mean follow-up period (3 
years). 
 
This study demonstrates that upper GI contrast study is useful in making the diagnosis.  
95% of cases were successfully diagnosed pre-operatively. Based on our findings, we 
advocate the use of upper GI series when Roux limb compression is suspected. In a series 
of 11 asymptomatic postoperative patients, Smith and White noted on upper GI series 
five (45%) exhibited a circumferential irregular narrowing with intact mucosal 
appearance, corresponding to the point at which the Roux limb passed through and was 
sutured to the transverse mesocolon (168). There exists, therefore, a possibility of having 
an abnormal radiographic appearance in the absence of symptoms.   
 
Our time-to-event analysis demonstrates that unlike internal hernias, which tend to occur 
later in the clinical course, Roux limb obstruction occurs much earlier after LRYGB.  
Several researchers have suggested that the commonly observed long time to presentation 
with internal hernias may be associated with a decrease in mesenteric fat with weight loss 
over time that results in a pulling through of sutures in the mesentery tissue (51, 137, 
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146). The observed time gap of 48 days to Roux limb obstruction development would be 
consistent with scar tissue development at the mesocolic rent compressing the Roux limb.   
 
Using interrupted stitches in place of a continuous stitch to close the mesocolic window 
appears to reduce the incidence of Roux limb compression. This is not unexpected as a 
single stitch is likely to have a purse-stringing effect when tightened, thus, narrowing and 
compressing the mesocolic window circumferentially around the Roux limb.  Another 
possibility may have been to leave the mesocolic space completely open but this would 
increase the risk of internal hernia. Using other types of suture material in place of silk to 
close this space may also have an impact in reducing cicatrix formation.  The risk of 
Roux limb compression together with the increased incidence of mesocolic internal 
hernias  may persuade some surgeons to choose an antecolic Roux limb placement to 
avoid these complications altogether. 
 
The primary limitation of this study is that it is retrospective, and it is therefore liable to 
all the potential factors that limit retrospective studies. In addition, the true incidence of 
Roux obstruction may have been underestimated in this study, as only symptomatic cases 
will have been reported. Furthermore, some cases may have been missed if they 
presented to other hospitals, although we urge our patients to return to our centre for any 
postoperative problem. All retrocolic LRYGBs will have been performed by one surgeon 
although various surgical trainees may have performed different parts of the operation 
including closure of the mesocolic defect. The impact of this is difficult to assess but all 
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operations were wholly supervised and assisted by the senior surgeon and thus there is no 
reason to suspect this will have had a significant effect on the results of this study. 
 
It may be argued that the 20 cases of Roux limb obstruction identified in this study were 
managed sub-optimally by release of cicatrix and circumferentially re-suturing Roux limb 
to mesocolic rent, a situation that may lead to a repeat of the event. An alternative would 
have been laparoscopic conversion to an antecolic alimentary limb. This is a considerable 
undertaking and it was judged as unjustifiable. None of the 20 patients presented in this 
series had any recurrence of Roux obstruction and none have presented to date with 
internal hernia. 
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Chapter 6 
 
 
6. IMPACT OF SURGICAL TECHNIQUES ON THE INCIDENCE OF 
INTERNAL HERNIA 
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This chapter entails two studies to investigate the influence of different surgical 
techniques on the incidence of internal hernias. 
 
6.1 Effect of the method of closing mesenteric defects and antecolic Roux 
limb placement 
 
6.1.1 Introduction 
It has been suggested that the laparoscopic approach results in fewer postoperative 
adhesions and thus reduced fixation of small intestine loops to the abdominal wall (126). 
The subsequent increased mobility of bowel loops leads to an increased risk of 
entrapment in hernia defects created as a result of the operation. Furthermore, it has been 
observed that the vast majority of internal hernias present months and not days after 
surgery (162). It has been postulated that the weight loss seen in these patients, typically 
occurring some months after surgery, results in reduced intraperitoneal fat which in turn 
leads to larger mesenteric defects. Potential internal hernia locations include: transverse 
mesocolon  defect,  enteroenterostomy  mesenteric  defect  and  Petersen’s  space  (the  area  in  
between the posterior aspect of the mesentery of the Roux limb and the transverse 
mesocolon). Complications (if left untreated) of internal hernia may include closed loop 
obstruction leading to bowel strangulation and/or anastomotic dehiscence as well as 
gastric remnant dilatation. Consequently, the patient may suffer bowel perforation (9.1%) 
and death (1.6%) (135). 
 
Previous studies have suggested that certain intraoperative factors may influence the 
incidence of internal hernia. Some of these include: closure of all potential defects with 
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running suture, using nonabsorbable suture, and antecolic Roux limb placement rather 
than retrocolic.  
 
To further investigate the effects of surgical technique, one of the surgeons in the study 
switched to using a continuous running closure of all mesenteric defects versus 
interrupted which was being done previously; the other surgeon switched to using only 
antecolic Roux limb placement. 
 
6.1.2 Aim 
This study aims to examine (i) when do internal hernias occur and what degree of weight 
loss has occurred by this stage, (ii) whether switching to running closure of mesenteric 
defects has an impact on incidence of internal hernia, and (iii) whether using an antecolic 
Roux limb placement affects the incidence of internal hernia. 
 
6.1.3 Methods 
6.1.3.1 Patients 
All patients undergoing LRYGB and developed symptomatic internal hernia requiring 
operative intervention between Jan 1, 2000 and September 15, 2006 was performed. For 
each case, age, gender, weight, body mass index (BMI) and time gap from initial surgery 
to secondary presentation with internal hernia were recorded. 
6.1.3.2 Setting 
Strong Health Bariatric Center, Highland Hospital 
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6.1.3.3 Review of cases 
This is a retrospective review of the notes and operative records to assess the method 
used (interrupted nonabsorbable versus continuous nonabsorbable) for closure of the 
mesenteric defects and whether an antecolic or retrocolic Roux limb placement was used. 
6.1.3.4 Statistical analysis 
GraphPad Instat version 3 (GraphPad Software Inc., USA) was used to perform statistical 
analysis. The data are expressed as mean +/- standard error of mean (SEM).  Odds ratios 
were calculated following Chi-square statistical analysis. A p value <0.05 was accepted 
as significant. 
 
6.1.4 Results 
A total of 2572 patients underwent LRYGB in the study period.   
 
Table 5.1 Incidence of internal hernia 
Total Internal hernia incidence 54/2572 (2.1%) 
Mean (±SEM) time to intervention 413 ±46 days;  (Range: 14-1978) 
Average % excess body weight loss 
(%EBWL±SEM) at intervention 
59 ±3.3;   (Range 9-108) 
 
Fifty four patients (50 women and 4 men) had to undergo further surgery to treat the 
complication of internal hernia. Mean age was 42, pre-LRYGB BMI was 50 kg/m2 and 
mean BMI at the time of reoperation was 34 kg/m2. Out of the 54 patients presenting with 
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internal hernias, 34 (63%) had undergone abdominal operations (mainly tubal ligations 
followed by Caesarian section, appendectomy and cholecystectomy) prior to their gastric 
bypass surgery. There was no significant difference in age and gender distribution in 
internal hernia patients compared to those patients with no internal hernia.  Overall, the 
site of internal hernia varied with transverse mesocolon hernias being the most common, 
followed  by  enteroenterostomy  and  then  Peterson’s  space  hernias  (Figure 5.1). In the 
antecolic  LRYGB  group,  internal  hernias  were  equally  distributed  between  Peterson’s  
defect and the enteroenterostomy defect. 
 
 
 
 
 
 
 
 
 
Figure 5.1 Nature of 54 internal hernias 
 
Table 5.2 demonstrates the impact of operative technique on internal hernia incidence.  
Subgroup analysis demonstrates the internal hernia incidence to be 2/357 (0.6%) in 
antecolic Roux versus 52/2215 (2.4%) in retrocolic Roux limb (Odds ratio= 4, P=0.03).   
Furthermore, of the  7  patients  presenting  with  a  Peterson’s  type  internal  hernia,  3  had  
Transverse 
mesocolon, 25 
Entero-
enterostomy, 22 
Peterson's 
space, 7 
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undergone interrupted closure and 4 had undergone continuous closure of this defect.  Of 
the 22 enteroenterostomy internal hernias, 13 underwent interrupted closure of the defect 
and 9 continuous closure. The impact of the suturing technique used on internal hernia 
incidence was not statistically significant, P = 0.79.  All the patients presenting with 
transverse mesocolic window internal hernias had interrupted closure of this space and 
not continuous suturing due to the increased theoretical risk of causing Roux limb 
compression with the latter. 
 
 
Table 5.2 Impact of operative technique on internal hernia incidence. 
 
 
Operative technique Internal hernia 
incidence 
p value 
Roux limb  Antecolic 2/357 (0.6%) Odds ratio= 4  
P = 0.03 Retrocolic 52/2215 (2.4%) 
Suturing of 
mesenteric defects 
Continuous 9/22* 
4/7** 
P = 0.79 
Interrupted 13/22* 
3/7** 
* Enteroenterostomy  defect;;  **Peterson’s  defect 
 
6.1.5 Discussion 
This work documents one of the largest reported series of internal hernias accrued over a 
six-year period. It demonstrates that internal hernias, on average, present some 14 months 
after the initial surgery. By this stage, the average weight loss has been around 44 kg with 
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the majority of patients experiencing 52-66%EBWL (mean 59%). Most (88%) of the 
patients with internal hernias were noted within the first two years after surgery. Only 
12% of patients were diagnosed afterwards. A previous review article estimates mean 
time to presentation at 9 months postoperatively but this is likely to be an 
underestimation because of the limited duration of follow-up (51). The observed weight 
loss in the time period between initial operation and internal hernia development certainly 
adds weight to the hypothesis of reduced intraperitoneal fat leading to larger mesenteric 
defects (129) and thus greater herniation risk. Paroz et al (130) have also noted a mean 
loss of 14.5 BMI units between primary operation and internal hernia presentation. 
Whatever the mechanism, the incidence of internal hernia in this study was around 2% 
and this makes it one of the most common long-term complications after LRYGB and, 
therefore, emphasizes the need for early exploration in patients presenting with symptoms 
and signs of bowel obstruction after LRYGB. Failure to do so may result in serious 
consequences of bowel ischemia and perforation. 
 
The location of internal hernias has been documented with transverse mesocolon hernias 
commonest followed by enteroenterostomy  and  then  Peterson’s  space  hernias.  The 
reported literature documents significant variation between studies in regards to hernia 
location. Garza et al (131) reported transverse colon hernias as the most common in their 
series. Interestingly, they did not encounter any enteroenterostomy hernias which 
comprise the second largest group in our series. Comeau et al (132) and Carmody et al 
(133)  reported  Petersen’s  hernias  as  the  most  common  site,  which  comprised  only  7%  in  
our population.  Paroz et al (130) and Eckhauser et al (134) reported enteroenterostomy as 
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the most common location. In a review article, Ianelli et al (51) found transverse 
mesocolon as the most common site of herniation which is in agreement with our 
findings. Similarly, Higa et al (135), in their review of 2000 consecutive gastric bypass 
patients, found transverse mesocolon as the most common location. This is in agreement 
with  previous  reports  though  some  studies  put  the  incidence  of  Peterson’s  hernias  above 
enteroenterostomy hernias (136). The reasons underlying the observed differences are not 
well known. We showed that Roux limb configuration plays a significant role as 
transverse colon hernias seem to be the most common amongst retrocolic Roux 
placement whereas enteroenterostomy hernias appear to be the most common in antecolic 
Roux placement. 
 
An attempt has been made to analyse what operative factors affect the risk of developing 
internal hernias. As such, an antecolic Roux limb by definition obviates the need to create 
a window in the transverse mesocolon and this in turn eliminates this site as a potential 
area for herniation. Our study demonstrates a fourfold increased risk of internal hernias 
when a retrocolic Roux limb is used. This has been noted previously (126, 137, 138, 132) 
and is also the reason why some surgeons have switched from the retrocolic to the 
antecolic route. However, others favour the reduced tension on the gastrojejunostomy 
with retrocolic Roux positioning. 
 
One of the surgeons evaluated in this study switched from interrupted closure of the 
enteroenterostomy  mesenteric  defect  and  Peterson’s  space  to  running  closure  on  the 1st of 
October 2003 whilst maintaining all other aspects of the operation unchanged. The 
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hypothesis was that a running closure would ensure a complete closure of the mesenteric 
defect. The rate of internal hernias before and after this change did not reveal any 
differences. This may be the result of low power of the study, particularly as the effect is 
likely to be small. Other surgeons who have modified their operative techniques, 
changing from absorbable to non-absorbable sutures and from interrupted to running 
sutures have noted a reduction in the incidence of internal hernias (51,135, 130, 169, 
170).  
 
Although not directly part of the analysis of this study, it is interesting to note that all the 
internal hernias in the study were managed via laparoscopic reduction and suturing of the 
mesenteric defect, no bowel resections were needed. 
 
This is a retrospective study and, therefore, is subject to all the potential flaws associated 
with this form of analysis. However, the  majority  of  the  data  was  captured  from  patients’  
operative notes which are transcribed according to a standardized template thus reducing 
the chance of missing data. The internal hernia incidence was dependent on our 
postoperative patients presenting with symptoms and signs warranting investigation. It is 
possible that the actual incidence of internal hernia may be higher if one includes cases 
that have not become symptomatic enough. Internal hernias may not necessarily present 
as an all or none effect with bowel obstruction. Small bowel may episodically become 
trapped and untrapped at the site of an internal hernia and these episodes may present 
quite subtly without typical bowel obstruction features. Therefore, clinician alertness is a 
factor in the correct diagnosis of internal hernias. Accurate calculation of the incidence of 
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internal hernias also depends on patients returning to this institution and not presenting to 
other  hospitals’  emergency  departments.  The  centre where the study was performed 
emphasises continued clinical follow-up after bypass with an overall follow-up of 80%. 
Lastly, errors may be introduced into the analysis from combining the outcomes of two 
different surgeons. Both surgeons in our group followed a standardised operative 
technique mirroring each other except for Roux limb positioning. 
 
Internal hernias are an important complication of LRYGB, presenting usually a year after 
surgery.  Not surprisingly, the use of an antecolic Roux limb eliminates the occurrence of 
the transverse mesocolic hernia thereby reducing the total incidence of internal hernia. It 
remains to be seen whether switching to a running closure of the mesenteric defects 
instead of interrupted sutures will significantly alter the incidence of internal hernia.    
 
6.2 Bioabsorbable glycolide copolymer staple-line reinforcement and 
internal hernia incidence 
 
6.2.1 Introduction 
Randomized controlled trials have shown that application of bioabsorbable glycolide 
copolymer staple-line reinforcement (SLR; GORE SEAMGUARD® Bioabsorbable 
Staple Line Reinforcement, WL Gore & Associates, Inc, Flagstaff, AZ) to the mesenteric 
defects created by the LRYGB procedure (Figure 5.2), or to the gastric pouch, decreases 
the rate of intraoperative staple-line bleeding and may reduce the incidence of 
postoperative gastrointestinal haemorrhage (171, 172).  
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6.2.2 Hypothesis and Aim 
In our unit, SLR was initially used in 2003 to mitigate staple-line bleeding in LRYGB 
procedures. We later observed adhesion formation at the cut edges of the mesentery 
(where the SLR had been placed) in patients undergoing a second abdominal operation 
(Figure 5.3). We hypothesised that such adhesiogenesis creates a strong tissue-fusion–
based bond that may prevent or decrease development of IHs after LRYGB. In January 
2003, one surgeon evaluated in this study switched from suturing closed all mesenteric 
defects created at surgery to applying bioabsorbable polymer SLR to all cut mesenteric 
ends and not formally suturing the defects. This is a retrospective study to examine 
whether use of SLR was associated with a decreased rate of IH formation after LRYGB. 
 
Figure 5.2 Intraoperative photograph 
showing stapling and concurrent 
application of bioabsorbable glycolide 
copolymer staple-line reinforcement to 
bowel and mesentery during a 
laparoscopic Roux-en-Y gastric bypass. 
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Figure 5.3 Photograph obtained at diagnostic laparoscopy performed 12 months after the 
patient underwent laparoscopic Roux-en-Y gastric bypass. The bioabsorbable glycolide 
copolymer staple-line reinforcement has created a bond (within circle) at the junction 
between the two mesenteric defects.  
 
6.2.3 Methods 
6.2.3.1 Patients 
Between January 2003 and September 2005, 1704 patients underwent LRYGB in our 
study. In 1350 cases (79%), all mesenteric defects were closed by suturing (3-0 silk). In 
the other 354 cases (21%), bioabsorbable polymer SLR was applied during stapling and 
the mesenteric defects created at surgery were left alone.  
6.2.3.2 Surgical technique 
6.2.3.2.1 Suture-closure group 
Pneumoperitoneum was established, and the omentum and transverse colon were 
reflected, exposing the ligament of Treitz. The small bowel was divided approximately 
30 cm from the ligament of Treitz with use of an ETS-45 stapler (Ethicon Endo-Surgery 
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Inc, Cincinnati, OH), and a second firing was made through the mesentery with a 2.5-mm 
cartridge. About 150 cm of the distal bowel was measured out to establish the length of 
the Roux limb. A side-to-side functional end-to-side enteroenterostomy was performed to 
create the anastomosis between the biliopancreatic and Roux limbs. The mesenteric 
defect was closed with running 3-0 silk sutures to mitigate the risk of an IH at the 
enteroenterostomy.  
A trial movement of the Roux limb in the antecolic antegastric position was performed to 
check for possible tension on its mesentery. If potential tension was observed, the stapled 
end of the Roux limb was passed retrocolic through an avascular rent in the transverse 
mesocolon into the lesser sac space and then retrogastric to the gastric pouch. The gastric 
pouch was fashioned by using a transverse application of an ETS-45 stapler (3.5-mm 
cartridge), followed by multiple vertical applications of the stapler to create a completely 
isolated proximal pouch with a volume of approximately 15 to 30 ml. The stapled end of 
the Roux limb was then positioned beside the gastric pouch and a side-to-side functional 
end-to-end gastrojejunostomy performed. The defect in the transverse mesocolon was 
closed circumferentially around the Roux limb with five interrupted 3-0 silk stitches to 
decrease the risk of a development of a mesocolic IH. To reduce the likelihood of IH 
formation  at  Peterson’s  space,  the  Roux  limb  was  tacked  to  the  peritoneal  undersurface  of  
the transverse mesocolon with running seromuscular 3-0 silk sutures. The 
pneumoperitoneum was then released and the trocars were withdrawn. 
6.2.3.2.2 SLR group 
The surgical technique used in the SLR group was the same as that in the suture-closure 
group except that the three mesenteric defects were not closed. Instead, the SLR sleeves 
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were loaded on an ETS-45 stapler when the first small-bowel division was made 
approximately 30 cm from the ligament of Treitz. A second firing was made through the 
mesentery in the same way. After creation of the enteroenterostomy anastomosis, one 2-0 
silk suture was placed on the antimesenteric border of the two bowel limbs just joined to 
prevent  kinking  at  the  anastomosis  and  to  serve  as  a  “crotch”  stitch  to  prevent  splaying  at  
the staple line. SLR was not applied at the mesocolic rent in cases in which a retrocolic 
Roux position was used. Instead, the defect in the transverse mesocolon was closed 
circumferentially around the Roux limb with five interrupted 3-0 silk stitches to decrease 
the risk of mesocolic IH.  
6.2.3.3 Data collection 
During the postoperative observation period, 43 patients presented with abdominal pain, 
nausea, vomiting, or a combination of these symptoms and were found at re-laparoscopy 
to have an IH; thus, the overall IH rate in the series was 3%. A retrospective review of the 
medical records of the 43 patients with an IH was conducted and the following 
information  recorded:  the  patient’s  age,  sex,  and  preoperative  BMI;;  the  LRYGB  
technique used (antecolic or retrocolic); whether the mesenteric defects were closed 
(suture-closure group) or not (SLR group); the amount of postoperative weight loss 
(percentage of excess body weight lost [%EBWL]); the total amount of time since the 
LRYGB operation, the postoperative time to presentation with IH symptoms; and the 
location of the IH. 
The information obtained on patients with IHs in whom SLR was used was compared to 
the information obtained on patients with IHs who had a suture closure. A second 
analysis also compared the suture and SLR groups but excluded patients with IHs in the 
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transverse mesocolon so that the LRYGB technique employed would not affect the 
results (because transverse mesocolic IHs do not occur after antecolic procedures).  
 
6.2.4 Statistical analysis 
Fisher’s  exact  test  was  used  in  both  analyses  to  compare  the  IH  rate  in  the  suture-closure 
group with that in the SLR group. A p value less than or equal to 0.05 was considered to 
represent a significant difference.  
 
6.2.5 Results 
The mean follow-up time in the entire series of 1704 patients who underwent LRYGB 
was 22 months. The mean time until postoperative presentation with abdominal 
symptoms in the 43 patients found to have an IH was about a year. These patients 
presented  in  the  hospital’s  emergency  department  or  an  outpatient  setting  with  an  acute  
illness characterized by abdominal pain, intolerance of oral intake, nausea, and vomiting. 
All IHs were managed laparoscopically by reduction of herniated small bowel and 
suturing of the mesenteric defect; no bowel resections were required.  
 
Table 5.3 shows demographic, operative, and follow-up data on the patients in whom an 
IH occurred after LRYGB. The IH rate among the 1350 patients who had a suture closure 
after LRYGB was 2.9%, whereas that among the 354 patients in whom SLR was used 
was 0.8%; the difference between the rates was significant (p = 0.01). Among the 43 
patients in whom IHs occurred, the baseline patient demographics, overall follow-up 
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time, amount of postoperative weight loss, and time to presentation with an IH were 
similar in the suture-closure and SLR groups.  
 
Because both antecolic and retrocolic Roux limb placements were performed in our series 
and a difference in IH rates between the two techniques has been described in our 
analysis.  Therefore  a separate analysis was conducted to determine the rate of IHs at the 
enteroenterostomy  and  Peterson’s  space  alone.  Thus,  the  herniation  rates in the suture-
only and SLR groups were calculated with exclusion of transverse mesocolic IHs. Data 
on patients in whom an IH other than a transverse mesocolic lesion occurred are shown in 
Table 5.3. Twenty of the twenty one patients with an IH in the enteroenterostomy or 
Peterson’s  space  had  a  suture  closure  at  LRYGB;;  only  one  had  application  of  SLR  (p = 
0.05 for difference in IH rates).  
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Table 5.3 Demographic, operative, and follow-up data in patients with a postoperative 
IH, according to whether LRYGB-created mesentery defects were closed with suture or 
SLR was applied 
  
Patients with any IH 
(n = 43) 
 
Patients with any IH 
except transverse mesocolon (n = 21) 
 Suture closure 
(n = 40) 
SLR applied 
(n = 3) 
Suture closure  
(n = 20) 
SLR applied 
(n = 1) 
 
Mean age, years (range) 
 
42 (23-58) 
 
48 (51-54) 
 
43 (25-56) 
 
41 
Sex: M/F 3/37 ½ 2/18 1/0 
Mean preoperative BMI 50 57 48 44 
LRYGB technique: A/R 0/40 2/1 0/20 1/0 
Mean no. of days since 
LRYGB (range) 
868 (222-1306) 833 (726-
947) 
900 (222-1306) 827 
Mean postoperative 
%EBWL 
57% 60% 62% 69% 
Mean no. of 
postoperative days to 
presentation with IH 
(range) 
332 (14-849) 412 (357-
506) 
336 (14-849) 506 
Location of IH      
   Transverse mesocolon  20 2 — — 
    Enteroenterostomy 16 1 16 1 
    Peterson’s  space 4 0 4 0 
 
Notes. IH denotes internal hernia; LRYGB, laparoscopic Roux-en-Y gastric bypass; SLR, 
staple-line reinforcement; BMI, body mass index; A/R, antecolic/retrocolic; and %EBWL, 
percentage of excess body weight lost. 
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6.2.6 Discussion 
A review of the records of the 43 patients with postoperative IH development in our 
series of 1704 who underwent LRYGB between January 2003 and September 2005 found 
that the IH rate in patients in whom bioabsorbable polymer SLR was applied when 
dividing the bowel and mesentery, without closure of the mesenteric defects thereby 
created, was significantly lower than that in patients who had suture closure of the 
mesenteric defects.  
 
This study is apparently the first to assess whether use of bioabsorbable polymer SLR in 
LRYGB would decrease the postoperative IH rate. We think that the presence of SLR on 
the cut edges of the mesentery evokes local adhesion formation and tissue fusion that 
creates a bond stronger than that provided by sutures, which may cut through the 
mesenteric tissue when the amount of fat decreases with weight loss. We hypothesize that 
this bond sealed the defects created at surgery and decreased the rate of post-LRYGB IH 
formation. In our opinion, SLR can therefore be used in LRYGB procedures not only 
with the objective of decreasing gastrointestinal bleeding (171) but also with the aim of 
reducing the postoperative IH rate.   Although we did not directly analyse the operative 
times in those cases where SLR was applied versus those cases where IH space was 
sutured close, it was evident that SLR usage had the added advantage of shortening 
operating time by avoiding the time-consuming process of suture closing the mesenteric 
defects. 
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Our study had the usual limitations associated with a retrospective design. It is possible 
that not all the cases of post-LRYGB IH that occurred in our overall series were 
identified by our record review. However, our mean follow-up time was long (22 
months), and because of the location of study, all our patients who had not moved away 
would  have  either  presented  in  the  unit’s  Emergency department when their IH symptoms 
developed or been referred back to us for treatment if they presented elsewhere. Another 
possible limitation is that both antecolic and retrocolic LRYGBs were included in our 
series and the different positioning of the Roux limb could have represented a 
confounding factor. However, this limitation was addressed by excluding transverse 
mesocolic IHs from our second analysis. 
 
 
It may be argued that the use of SLR is not cost effective, particularly because of the low 
IH rates in some recent studies [0.4% (126), 0.2% (173), and 0% (174)].  SLR application 
adds cost to each surgery (around GBP 90 per firing of 1 stapler cartridge).  Our opinion 
is that in the light of the costs of hospital or outpatient visits for unexplained episodic 
abdominal pain, tests ordered to investigate the pain, and, eventually, reoperation, 
prophylactic use of SLR may save money. Additional studies are required to compare 
both the costs and outcomes of LRYGB procedures that use SLR with those of other 
LRYGB techniques.  
 
In conclusion therefore, the results from this study suggest that application of 
bioabsorbable glycolide copolymer SLR at stapling of the bowel and mesentery may be 
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one useful option in reducing IH .  Clearly further investigation of this technique is 
needed combined with a cost to benefit analysis. 
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Chapter 7 
 
 
7. ROOT CAUSE ANALYSIS OF BOWEL OBSTRUCTION AFTER LRYGB 
USING OBSERVATIONAL CLINICAL HUMAN RELIABILITY ASSESSMENT 
(OCHRA) 
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7.1 Introduction 
Advanced laparoscopic surgical procedures are characterised by multiple steps. Not only 
does each step have to be performed meticulously and precisely but also in the correct 
sequence to ensure desired outcomes are achieved consistently. Failure to so may lead to 
adverse events and surgical complications. Observational Clinical Human Reliability 
Assessment (OCHRA) is a technique that allows analysis of the mechanisms underlying 
technical errors and human factors that shape the performance of surgeons (175).   
 
The study of human error in industry typically uses simulation exercises to predict the 
occurrence of errors in real circumstances (176).  However, these predictions need to be 
validated by observing and collecting data from real life situations. This led to the 
development of human reliability analysis, a method of systematically evaluating task 
performance and the potential consequences of errors. The technique of human reliability 
analysis has been used for years in high-risk industries (such as nuclear power plants) to 
study and enhance human performance of complex dynamic interactive tasks (177-180). 
The aim of this method is to identify what causes errors and what corrective action can be 
taken to reduce the likelihood of the error recurring. 
 
Surgery requires a high level of manual dexterity. Typically operations can easily be 
broken down into a series of tasks consisting of steps. Deviation from standard execution 
of a step or from the sequence order of steps can lead to errors. Laparoscopic operations 
ideally lend themselves to the human reliability assessment approach as they are 
performed on visual display monitors with the facility to routinely record the procedures 
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and thus create a source of observational data that can be used for error analysis at a later 
time.  
 
The application of the OCHRA technique in laparoscopic surgery has been performed in 
the setting of laparoscopic cholecystectomy (175,181), laparoscopic gastrojejunostomy 
and cholecystojejunostomy (182), laparoscopic pyloromyotomy (183) and cataract 
surgery (184).  
 
In the study by Tang et al (175), 200 videos of laparoscopic cholecystectomy performed 
by 26 different surgeons were analysed for errors. A total of 38062 steps were noted and 
2242 errors identified. On average, each operation was found to have 11 errors of which 4 
were consequential (had a negative impact). Dissection of Calot’s triangle was noted to 
have the highest concentration of errors and all conversions and postoperative 
complications resulted from errors committed during this task. 
 
Talbpour et al (182) reviewed 20 videos of laparoscopic bypass operations for advanced 
gastric and pancreatic cancer (gastrojejunostomy and cholecystojejunostomy). The 
majority of errors occurred during the task of intracorporeal suturing and consisted of 
concentration lapses (n=1321), misjudgements (n=209) and impaired coordination 
(n=108) amongst others. In the same study errors were also used as a measure for the 
proficiency gain curve during the training phase of this operation.  
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Tang et al (183) analysed 50 videotapes of laparoscopic pyloromyotomy performed in a 
Dutch hospital. They found an average of 6 errors per operation. Most of the errors were 
of  the  execution  type  and  concentrated  in  task  3  (“splitting  the  incision  previously  made  
over  the  pylorus”).    Furthermore, in addition to human errors such as use of excessive 
force during dissection, the study also identified that poor design and functionality of the 
laparoscopic instruments also played a role in the occurrence of errors. 
 
OCHRA has also been used in the setting of surgical training. Tang et al (185) applied the 
technique to a training model of laparoscopic cholecystectomy performed by 60 junior 
surgical residents in an ex-vivo pig model. They identified 1067 errors (331 
consequential and 736 non-consequential). Not surprisingly in this cohort, the majority of 
consequential errors were related to the use of excessive force (execution error).  The 
study also documented a wide variation in the number of errors between trainee surgeons.  
On the basis of their findings,  the  authors’  conclusions  were  that  laparoscopic  training  
should be structured, menu-driven and individualised. 
 
These studies demonstrate that any given surgical procedure can be divided into a series 
of tasks and that each task is subject to errors.  These errors can be classified in relation to 
the underlying causative mechanism either into procedural and execution errors.  
Procedural errors correspond to the ability of the surgeon to execute a number of steps in 
the correct order. Execution errors are those resulting from a failure of the surgeon to 
execute a specific component step of the operation in the correct manner. The end result 
of an error may be neutral (inconsequential error) or negative (consequential errors).   
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7.2 Applying OCHRA to LRYGB complications – IH and Roux compression 
A number of studies have looked at the technique of OCHRA retrospectively to analyse 
the nature of technical errors that can occur during a particular operation. This yields 
useful information on what are the critical parts of an operation, and what mechanisms 
can  be  placed  to  minimise  errors  in  these  segments,  so  called  ‘error-reduction’  
mechanisms. Such surgical error reduction systems may include better cognitive training 
to reduce procedural errors, and practical training in laparoscopic box trainers or virtual 
reality simulators, which may help reduce execution errors. 
 
However, to the best of our knowledge, no one has used OCHRA to analyse a particular 
task within a surgical procedure (known to have a postoperative complication) to see if 
there is any association with errors observed during the performance of that task and that 
particular postoperative complication.  
 
In the previous chapters, I described the incidence and trends of two causes of bowel 
obstruction observed after LRYGB – internal hernias (IH) and Roux limb compression. 
The current knowledge on the operative factors that may lead to internal hernia formation 
and Roux limb compression were described. Retrocolic Roux limb placement causes 
significantly more internal hernia formation than antecolic placement. Also, the use of 
interrupted sutures results in less Roux limb compression than running sutures but does 
not cause a statistically significant difference when it comes to IH at the TM.   
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To date, there has been very little investigation of the surgical errors at the index 
operation that could favour an internal hernia or Roux limb compression. It is possible 
that errors occurring during the suturing of the mesenteric defects may lead to, or 
contribute to, the development of post-operative complications. Laparoscopic surgery 
requires a high skill level and thus a significantly higher error rate is likely.  
 
In order to answer the aforementioned question, in this chapter, we describe the use of 
OCHRA on operative videos of (i) LRYGB complicated by IH, (ii) LRYGB complicated 
by Roux compression and (iii) LRYGB without complications to see if there is any 
association between any observed errors at the index surgery and incidence of IH or Roux 
compression postoperatively. 
 
On completion of the data collection, the errors identified can be correlated with their 
resultant complications, to identify the errors that play a role in the occurrence of internal 
hernias as oppose to Roux limb compression. If analysis shows that most errors are 
procedural, this will highlight the need to reinforce operative rules and may indicate that 
training needs to focus more on menu-driven execution. If on the other hand, errors are 
mainly due to poor suturing technique, this emphasises the need for more practice of this 
specific skill. In this way, the study may help to identify the corrective action needed to 
reduce the incidence of internal hernia and Roux limb compression.    
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7.3 Aim 
The aim of this study is to analyse intraoperative performance and identify technical 
causes underlying the occurrence of internal hernia and roux compression. 
 
7.4 Methods 
7.4.1 Study cohort selection 
The study cohort was retrieved from a comprehensive database of 2215 consecutive 
retrocolic LRYGB procedures at the University of Rochester Medical Centre (URMC) 
between 2000 and 2005. Forty-seven patients developed either an internal hernia at the 
transverse mesocolon or Roux limb compression postoperatively. Of those, 25 full-length 
videos could be retrieved. Twenty-one operative videos of patients without any 
complication (median follow up of 7 years) were randomly selected. The videos/DVDs 
were coded, with the observer blinded to the outcome of the operation. For each 
video/DVD, the patient ID number, gender, preoperative BMI and weight loss was 
recorded. 
 
7.4.2 OCHRA 
As described earlier, OCHRA is a method to analyse technical errors occurring during 
surgical performance. These methods were derived from similar techniques used in other 
high-risk industries (186,187). The procedure consists of a formal task and error analysis, 
followed by observations of the operation. Finally, observations with a negative outcome 
were analysed in order to identify common anomalies from the normal process.  
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7.4.2.1 Task and subtask analysis 
Our technique of LRYGB has already been described in the previous chapter.  The 
operation is lengthy and consists of numerous complex steps. A task analysis has been 
performed and divided the procedure into 27 steps (Table 6.1). For the purposes of this 
study, we have selected those videos of LRYGB for analysis where the outcome has been 
either (i) IH at TM or (ii) Roux compression. We have also included a control arm where 
the patients, to date, have not suffered from neither of the two complications. As the 
study is only interested in the postoperative complications of IH at TM and Roux 
compression, the task analysis is focused on steps of the operation when the Roux limb is 
secured in the transverse mesocolon rent in order to close this potential internal hernia 
defect.  
 
Table 6.1 Task analysis for retrocolic LRYGB 
No.  Task 
1. Patient is placed on the operating table in the supine position with foot board 
and leg straps.  
2. General anaesthesia is administered. 
3. The patient's abdomen is prepped and draped in sterile fashion including  use 
of Opsite. 
4. The abdominal cavity is entered through a small, transverse,  Left Upper 
Quadrant  incision with the bladeless 12-mm trocar loaded with the 10-mm 
O-degree laparoscope under laparoscopic observation. 
5. A pneumoperitoneum is established to 15-mmHg pressure carbon dioxide.  
6. A total of 4 bladeless 12-mm trocars are passed obliquely through the 
abdominal wall, including left upper quadrant, left flank and umbilical 
midline. 
7. At this stage the omentum and the transverse colon are then reflected 
cephalad to expose the ligament of Treitz.   
8. The small bowel is the divided approximately 30-cm from the ligament of 
Treitz with the ETS-45 stapler and this is followed by a second firing made 
through the mesentery with the 2.5-mm cartridge. 
9. Distal bowel is measured to 150-cm and this would be the length of the 
Roux limb. 
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10. A side-to-side functional end-to-side enteroenterostomy is then performed 
by tacking the afferent limb to the 150-cm mark on the Roux limb making 
parallel antimesenteric enterotomies and firing the ETS-45 stapler into the 
lumen of each. 
11. The resulting enterotomy is closed with interrupted 3-0 Vicryl and the 
mesenteric defect is closed with running 3-0 silk sutures. 
12. The stapled end of the Roux limb is passed into the lesser sac space  through 
an avascular rent made with the harmonic in the transverse mesocolon . 
13. The gastrocolic ligament is divided and the Roux limb is seen within the 
lesser sac space below. 
14. A small incision is then made below the xiphoid process and a 10-mm blunt 
probe is passed into the abdominal cavity under laparoscopic observation to 
retract the left lateral segment of the liver medially exposing the GE 
junction. 
15. The phrenogastric membrane on the left side of the GE junction is sharply 
then bluntly dissected to free the angle of His. 
16. Next a window is made in the lesser omentum along the lesser curvature of 
the stomach approximately 3-cm inferior to the right side of the GE junction. 
17. Again the retrogastric space is entered. 
18. A transverse application of the ETS-45 stapler with the 3.5-mm cartridge is 
followed by multiple vertical applications of the same type of stapler 
creating a completely isolated proximal gastric pouch approximately 15 to 
30 cc in volume. 
19. Next the stapled end of the Roux limb is passed into the retrogastric space to 
lie next to the proximal gastric pouch and a side-to-side functional end-to-
end gastrojejunostomy is performed by first making an anterior inferior 
gastrotomy in the proximal gastric pouch and a matching antimesenteric 
enterotomy near the stapled end of the Roux limb, applying the ETS-35 
stapler to two-thirds of its depth into the lumen of each and firing. 
20. The resulting enterotomy is closed with a layer of running 3-0 Vicryl and a 
second outer layer of interrupted seromuscular 3-0 Vicryl. 
21. The 34 French Ewald orogastric tube is introduced, making sure an easy 
passage  across the anastomosis is achieved and is then backed into the distal 
oesophagus. 
22. This is followed by the leak test; With the Roux limb occluded, the 
anastomosis is submerged under saline and distended with oxygen via the 
Ewald tube . Multiple distentions while submerged to confirm there is  no 
evidence of leak. 
23. The defect in the transverse mesocolon is circumferentially closed around the 
Roux limb with 5 interrupted 3-0 silk stitches.   
24. The Roux limb is tacked to the peritoneal undersurface of the transverse 
mesocolon with running seromuscular 3-0 silk sutures. 
25. The pneumoperitoneum is allowed to escape. 
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26. The trocars are withdrawn under laparoscopic vision ensuring there is no 
bleeding from the port site. 
27. The wound is irrigated with normal saline and infiltrated with 0.25% 
Marcaine and closed with staples. 
 
Task step 23, the closure of the mesenteric window was further broken down into 8 
subtasks. Table 6.2 demonstrates this task analysis for this particular part of the LRYGB 
operation. The defect in the transverse mesocolon is circumferentially closed around the 
Roux limb with 5 interrupted 3-0 silk stitches. The Roux limb is then tacked to the 
peritoneal under surface of the transverse mesocolon with running seromuscular 3-0 silk 
sutures. The stitches are placed at specific points as described below. The steps are 
illustrated in Figure 6.1.   
 
Table 6.2 Task analysis for closure of mesenteric window (step 23) 
Step Sub-Task  Description  
1 Stitch 1 Stitch between transverse mesocolon and 
Roux limb mesentery left side. The stitch 
is then secured and the knot ends are cut 
2 Stitch 2 Stitch 2: Stitch between transverse 
mesocolon and mesenteric side of Roux 
limb  left  side  (2  o’clock).  The  stitch  is  
secured and the knot ends are cut 
3 Stitch 3 Stitch between mesocolon to 
antimesenteric  Roux  limb  (12  o’clock).  
The stitch is secured and the knot ends are 
cut 
4 Stitch 4 Stitch between mesocolon to Roux limb, 
right  side  (9  o’clock).  The  stitch  is  then  
secured but the ends are left uncut 
5 Stitch 5 Stitch between transverse mesocolon and 
Roux limb mesentery right side. The stitch 
is secured but the ends are left uncut 
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6 Running from bottom Running suture from stitch 5 towards 
stitch 4 
7 Running from top Running suture from stitch 4 towards 
stitch 5 
8 Securing final knot Securing of sutures by tying together ends 
of stitch 5 and stitch 4.   
 
 
Figure 6.1 a) Stitch 1 between transverse mesocolon and Roux limb mesentery left side. 
Stitch 2 between transverse mesocolon and mesenteric side of Roux limb left side (2 
o’clock).  b)  Stitch  3  between  mesocolon  to  antimesenteric  Roux  limb  (12  o’clock).  Stitch  
4 between  mesocolon  and  Roux  limb,  right  side  (9  o’clock).  Stitch  5  between  transverse  
mesocolon and Roux limb mesentery right side. c) Running suture from bottom, from 
stitch 5 up to stitch 4. d) Running suture from top, from 4 towards suture 5. The ends of 
stitch 4 and 5 are then tied together. 
 
A B 
D C 
 2 
  1 
   4 
     3 
5 
   7 
6 
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6.4.2.2 Categorisation of errors  
An  error  was  defined  as  “something  that  was  not  desired  according  to  a  set  of  rules”  or  
“something  that  led  to  a  consequence  outside  the  acceptable  limits”  (175). In accordance 
with this definition, consequential and non-consequential  (“near  misses”)  errors  were  
recorded. The categorisation of errors was based on External Error Modes (EEM), a 
categorisation system originally developed for human reliability assessment for work 
processes in nuclear power plants (186). The system was previously adopted and 
validated for laparoscopic surgery (181). There are 6 modes describing procedure errors 
and 4 modes describing execution errors. Some errors can potentially be followed by an 
immediate consequence (e.g. bleeding). If such a direct consequence was present, this 
was also recorded (Table 6.3). 
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Table 6.3 Error categorisation using External Error Modes and descriptions of 
consequential errors 
 EEM* Examples Direct consequence (examples) 
Procedural 
errors 
Step not done Stitch 1 not done  
      Lose knot 
Bleed (oozing) 
Pulsating bleeding 
Cutting through tissue 
Haematoma 
Perforation of bowel 
Tissue avulsion 
 
 
Step partially completed Number of throws too little 
Step repeated Two stitches in position 3 
Step done in addition Additional stitch between 1 and 2 
Second step done instead 
of first 
Stitch 2 before stitch 1 
Step done out of 
sequence 
Begin with stitch 3 
Execution 
errors 
Too little - Grasped too much tissue 
- Stitch is too clockwise 
 
Too much - Grasped too little tissue 
- Stitch is too anticlockwise 
Wrong  Wrong knot tying technique 
Wrong object Wrong instrument used 
 
In order to document errors, a scientific event logging software for observational data 
collection was used (Observer XT, Version 8, Noldus Information Technology Inc., 
Leesburg (VA), USA). Observer XT is a professional, manual event recorder for the 
collection, management, analysis and presentation of observational data. It allows the 
study of behavioural processes at a level of detail that cannot be obtained without an 
automated system. The observer watches a video, and simultaneously enters their 
observations (in this study errors committed) in the form of codes according to what 
he/she has specified in an earlier phase. Each step in the closure of the rent was observed 
to record the errors committed, as well as any resulting consequences or corrective 
actions taken. The screenshot for the above is displayed in Figure 6.2. 
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A second assessor rated all videos after being trained on how to use the software and on 
the error categorisation system.  
 
 
Figure 6.2: Observer XT screenshot 
 
 
7.4.3  Rent size 
In addition to errors, the size of the incision at the transverse mesocolon was estimated. 
During playback of the operative videos, image capture techniques were used to take 
stills of the mesenteric rent at the time of creation and prior to step 1. It was ensured that 
the image captured also included surgical instruments (needle driver, grasper) or needle 
in the same plane as the rent. The known length of the tip of the instrument in reality and 
the according distance on the image was used to generate a scale. The scale was then used 
to estimate the approximate size of the rent (Figure 6.3). 
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Figure 6.3 Estimation of rent size at the transverse mesocolon. The known length of the 
tip of the instrument (e.g. grasper = 2.5cm) and the according distance on the image (G) 
was used to generate a scale.  The distance of the rent on the image (R) was measured and 
the scale used to approximate the size of the rent in reality. 
 
 
7.4.4 Statistical analysis 
The Statistical Package for the Social Sciences software [Version 18.0.2, SPSS Chicago 
(IL), USA] was used. Inter-observer  reliability  was  assessed  using  Cohen’s  kappa  using a 
binary datasheet (same error detected by both observers). Non-parametric tests were used, 
as data were not normally distributed (as shown by detrended QQ plots). For categorical 
R 
G 
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data the chi-square test was used. A linear regression model was applied to analyse the 
predictive implication of individual error types.  
 
7.5 Results 
The analysis was performed  on  46  cases,  12  in  the  internal  hernia  group  (“IH”),  13  in  the  
Roux  limb  compression  group  (“RC”)  and  21  in  the  control  group  (“control”).  There  was  
no difference for age, gender, preoperative BMI or average weight loss after 1 year for 
the three groups (Table 6.4).  
 
Table 6.4 Patient demographics  
 
 
 IH group 
N=13 
RC group 
N=13 
Control group 
N=21 
p-value* 
Age  40 (23-58) 39 (25-55) 44 (26-59) 0.534 
Female n=10 n=11 n=20 0.473 
BMI pre 53 (40-69) 47 (39-54) 50 (40-87) 0.110 
BMI 1 year post 33 (28-49) 32 (23-37) 32 (25-68) 0.470 
BMI drop 1 year 19 (12-40) 16 (15-19) 15 (10-25) 0.069* 
All values median (range), p-values calculated by Kruskal Wallis for continuous data, 
ANOVA for categorical data 
* after removing outlier (BMI loss of 40), the intergroup difference is clearly not 
significant (p=0.187) 
 
Inter-observer reliability for error detection was high with  a  Cohen’s  κ=0.849.  A  total  of  
141 errors were detected for all cases.  
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Table 6.5  Overall number of errors 
 
Group Number of errors (mean) 95%CI SD 
1 0.67 0.29-1.05 0.76 
2 2.85 1.83-3.86 1.67 
3 3.82 2.48-5.16 1.99 
Analysis was performed for each complication group (1=control, 2= roux compression, 
3= internal hernia): There is a highly significant overall effect between the groups: 
p=0.00002; chi2=21.7; df 2 (Kruskal Wallis) 
 
There was a significant difference in the number of errors between the three groups, 
indicating that on average in the IH group 5.7 times and in the RC group 4.5 times more 
errors were detected than in the control group (average errors: IH=3.82, RC=2..85, 
control=0.67, p<0.001). This effect was also present between the two complication 
groups, with significantly more errors in the IH group compared to the RC group 
(p=0.025).  The  strongest  effect  was  found  for  the  EEM  “step  not done”  for  the  IH  group  
(Table 6.6). Analysing which steps were not done, it was shown that steps 1, 6 and 7 were 
missed significantly more often in the IH group (Table 6.7). These steps are exclusively 
stitches between the mesentery of the Roux limb and colonic mesentery medially and 
laterally.   Summary statistics are presented below, the frequency and nature of the errors 
observed in the study are given in Appendix 2.. 
 
 
 
 
Table 6.6 Kruskal Wallis results for External Error Modes (EEM) compared between 
the complication groups and the control group  
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EEM Internal 
Hernia 
Roux limb compression 
Step not done 0.026 0.266 
Step partially completed 0.046 0.248 
Step repeated 0.527 1.000 
Step done in addition - - 
Second step done instead of 
first 
- - 
Step done out of sequence - - 
Too little 0.705 1.00 
Too much 1.00 0.114 
Wrong 0.273 0.273 
Wrong object - - 
 
 
Table 6.7 ANOVA results for subtask analysis of errors for IH group 
 
Task Description p-value 
1 Stitch 1 <0.001 
2 Stitch 2 0.209 
3 Stitch 3 0.209 
4 Stitch 4 0.440 
5 Stitch 5 0.315 
6 Running suture from bottom 0.003 
7 Running suture from top 0.000 
8 Securing final knot 0.155 
 
Consequential errors and size of mesenteric window 
There was no relationship between observed intraoperative bleeding/haematoma and 
Roux compression (p = 0.793). As shown in Table 6.8 the size of the mesenteric window 
did not predict the occurrence of either complication (median rent size IH=1.80cm, 
RC=2.05cm, Control=1.44cm, p=0.321). 
 
Table 6.8 Rent size measurements- Groups 1-3 
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ID number Rent size (cm) ID number Rent size (cm) ID number Rent size (cm) 
066043 3.750 568588 1.125 2 1.296 
101970 0.990 569778 2.813 3 0.800 
308997 1.368 573338 2.420 4 2.400 
374290 6.480 573479 2.127 5 1.800 
390382 1.571 573866 0.833 6 2.979 
426501 0.415 574032 2.500 7 2.092 
437325 3.750 575008 0.000 8 1.917 
480946 1.000 576490 0.167 9 4.200 
535528 3.273 576715 0.933 10 3.017 
536900 0.692 577478 1.143 11 2.618 
543584 1.389 578114 1.440 12 2.500 
543584a 1.458 580202 3.750 13 2.782 
554965 1.733 580873 0.938 14 2.541 
559198 4.000 582746 1.260 15 1.875 
563960 1.800 585057 1.705 16 4.375 
565963 3.150 1 0.563 17 1.011 
 
Logistic regression 
Logistic regression including missing stitches for all different positions (tasks) reveals 
that missing the first stitch between mesentery of the Roux limb and the transverse 
mesocolon was the only stitch significantly predicting an internal hernia (B=1.727, 
p=0.025). All other stitches did not predict a complication. Hence, missing the first 
intermesenteric stitch on the left side of the Roux limb independently leads to a higher 
risk for internal hernias.  
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7.6 Discussion 
A detailed study of the errors that occur during the closure of the mesenteric defect at the 
transverse mesocolon, and their resultant complications has been presented so that 
corrective action to reduce the likelihood of internal hernia or Roux limb compression 
may be undertaken. The analysis performed suggests that the main technical reasons for 
the occurrence of internal hernias at the TM after LRYGB are missing stitches between 
colonic and ileal mesentery on the medial and/or lateral side. This is plausible as 
anchoring the Roux limb along the edges of the mesocolic rent would prevent herniation 
of the former through the latter. It is interesting to note that the analysis demonstrates that 
a missed stitch at positions 1, 6 and 7 (the stitches approximating Roux limb mesentery 
and colon mesentery) are the most likely associated with postoperative occurrence of 
internal hernia.  My own work has already demonstrated that internal hernias present on 
average 14 months after the index operation, a time interval during which patients have 
lost significant amounts of weight (median weight loss 44 kg). The loss of mesenteric fat 
leads to a widening of the intermesenteric space and the likelihood of internal hernias 
rises. It was hypothesised previously that the internal hernias might occur due to pulling 
through of sutures. Our results, however, suggest that a technical error may also be a 
preventable cause of this complication. A failure of standardised approximation of the 
mesenteries of small bowel and colon was shown to significantly increase the rate of 
postoperative internal hernias and a substantial number of complications can potentially 
be prevented using the correct technique 
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One would expect that Roux compression would most likely be associated with too many 
stitches or bleeding at the site where stitches were placed creating excessive cicatrix 
formation. However, our analysis did not reveal any such association. For the Roux limb 
compression group the overall number of errors was also significantly higher, although it 
was not possible to establish a relationship to a single error type. This may be due to a 
small sample size but it is also possible that other factors, such as local inflammatory 
response contributing to the occurrence of this complication. 
 
The size of the avascular mesocolic rent created also does not appear to influence the 
incidence of either internal hernia formation or Roux compression. One would expect that 
the larger the rent created, the greater the risk for internal herniation and, conversely, the 
smaller the rent, the higher the chance of Roux compression. However, the study findings 
do not demonstrate any association between mesocolic rent size and complications of 
internal hernia and Roux compression. 
 
The LRYGB procedure has numerous steps and our study has demonstrated that a 
subsection of this operation can be successfully analysed using OCHRA. By analysing 
the videos of operations which are known to result in postoperative complications, the 
OCHRA system provides a novel and interesting approach in identifying those key 
intraoperative steps that may have either been missed or might have led to errors. The 
objective  of  such  analysis  would  be  to  draw  surgeons’  focus  to  these  key  steps  in  an  
attempt to reduce their incidence and, thus, reduce the postoperative complication rate. 
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This study has utilised a scientifically approach to demonstrate that a standardised closure 
technique of the mesenteric gap is likely to prevent the occurrence of internal hernias. 
 
To my knowledge, this is the first application of OCHRA within the field of bariatric 
surgery. The use of the OCHRA system to assess the quality of surgical operative 
performance has many advantages over retrospective population-based research. In the 
first instance, the system provides objective and comprehensive tracking of errors related 
to the performance of a specific operation. Secondly, it identifies hazard zones of an 
operation where technical errors occur most commonly and are likely to jeopardise 
clinical outcome. The objective is to reduce surgical complications by placing steps to 
reduce errors in the particular hazard zones of an operation. 
 
Although auditing of clinical data is important for day-to-day service quality assessment, 
it usually does not allow for the analyses of root causes of undesirable outcomes. It is 
worrying that unless complications accumulate, a problem may not be identified at all. 
Introducing human reliability methods into regular quality assessment of a surgical 
service could have an immediate and unambiguous impact on clinical practice, as 
demonstrated in this study. OCHRA enables the clinician to identify hazard zones and 
technical errors that are likely to jeopardise clinical outcome. The results of this study 
have direct applications and should be used to adapt operative practice in order to reduce 
complications. In addition, regular structured reviewing and critical self-appraisal of 
videotaped operations may be useful for surgeons to continuously improve their 
technique (188). Recent advances in video recording technology and increased 
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availability of storage capacities using hard-drives and other digital media favour this 
approach. Modern laparoscopic stacks often provide software for the setup of video 
libraries to easily access full-length operating videos.  
 
However, there are also limitations to this study. Above all, it takes a significant amount 
of time to assess full-length videotapes. Although assessment time can be reduced with 
increasing experience and by selective reviewing, as demonstrated in the present study, 
time remains an insurmountable obstacle for surgeons with a busy practice. Further 
technological developments, such as pattern recognition software to facilitate task 
analysis and error identification may be required before these methods can be 
implemented into daily clinical practice. 
 
Secondly, the focus of the study is on retrocolic, retrogastric bypass only, and specifically 
on the steps involved in the closure of the transverse mesocolic rent.  Furthermore the 
operations reviewed were performed in a standardised way by one surgeon and other 
surgeons may perform the same retrocolic LRYGB but with their own nuances. Thus the 
question remains whether the results of this study can be extrapolated more widely to all 
cases of LRYGB. 
 
Laparoscopic procedures are routinely recorded and thus observational material is readily 
available to carry out a retrospective analysis of surgical performance using a HRA 
technique. Future work should look at analysing videos of the index operations of cases, 
which resulted in a complication so that we can learn from the errors committed at the 
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index surgeries. Furthermore, the knowledge gained can be used to focus training in those 
parts of the operation where most errors occur, and by knowing the nature of errors more 
specific skills training can be applied depending on whether errors are executional or 
procedural. More than any other surgery, laparoscopic surgery lends itself to OCHRA. 
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Chapter 8 
 
8. PRELIMINARY EXPERIENCE USING ANTECOLIC ANTEGASTRIC LRYGB 
WITHOUT MESENTERIC DIVISION 
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8.1 Introduction  
Internal  hernias  after  LRYGB  will  occur  despite  the  surgeon’s  best  efforts.    Previous  
chapters have described in detail the incidence, presentation, and diagnosis of IH as well 
as techniques to reduce their incidence both in terms of surgical technique as well as 
through using alternative methods such as staple line reinforcement.  My own work is in 
agreement with other authors demonstrating the antecolic antegastric technique (AA-
LRYGB) reduces the risk of IH in comparison to the retrocolic technique, most likely due 
to the absence of the transverse mesocolic defect (189-192). Table 7.1 summarizes the 
findings of all papers published to date on the incidence of internal hernias in AA-
LRYGB.  The mean incidence appears to be around 3% but with a wide range from range 
from  0 to 14.4%.  This wide range reflects the variations in technique used by different 
surgeons. 
 
Traditionally, during AA-LRYGB small bowel mesentery is usually divided to release 
potential tension from the gastrojejunal anastomosis. The division of the mesentery 
creates mesenteric defects.   Steele et al (193) performed AA-LRYGB with division of 
the mesentery and closure of all mesenteric defects. They found the incidence of IH to be 
zero. Other surgeons have reported their findings with AA-LRYGB with division of the 
mesentery but without closure of IH spaces. These surgeons have suggested that as the 
antecolic technique creates fewer defects than the retrocolic technique, routine closure of 
mesenteric defects is not necessary. Finnell et al found this to be the case, operating on 
300 patients with a mean follow-up of 18 months, with no patients developing an internal 
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hernia (174). However, another report describes an IH incidence of 6.9%, with 6.2% 
arising  at  Petersen’s  space  (134).   
 
Table 7.1 Incidence of IH in AA-LRYGB 
Author Year Patients IH 
incidence 
(%) 
IH at JJ (%) IH at 
Petersen’s  
space (%) 
Division of 
mesentery 
Closure of 
mesenteric 
defects/ 
spaces? 
Mean/median 
follow-up 
Steele et al (163) 2008 205 0 0 0 Yes Yes nr 
Ahmed (158) 2007 357 0.6 0.3 0.3 Yes 
Petersen only 
[SLR at JJ] 34 months 
De La Cruz-Munoz et al 
(166) 2010 1727 0.05 0 0.05 Yes JJ only 53 months 
Muller et al (160) 2007 33 6.1 6.1 0 Yes JJ only 35 months 
Rodriguez et al (162) 2010 187 14.4 9 5.4 Yes Yes 36 months 
Nelson et al (103) 2006 326 0.3 0.3 0 Yes Yes  16months 
Escalona et al (161) 2007 454 0.6 0.4 0.2 Yes Yes 16 months 
De La Cruz-Munoz et al 
(166) 2010 352 11.7 10 1.7 Yes No 101 months 
Finnell et al (123) 2007 300 0 0 0 Yes No 18 months 
Bauman and Pirrello 
(117)  2009 1,047 6.9 0.7 6.2 Yes No nr 
Comeau et al (115) 2005 731 3.3 1.3 2 Yes No nr 
Gandhi et al (165) 2009 702 2.1 2.1 0 Yes Noa nr 
Rogula et al (159) 2007 2,343 0.3 nr nr Yes Nr nr 
Rodriguez et al (162) 2010 172 1.1 1.1 0 No Yes 26 months 
Iannelli et al (164) 2007 625 1.6 1.6 0 No Yesb nr 
Cho et al (120) 2006 1400 0.2 0 0.2 No No 11 months 
Abasbassi et al (116) 2011 652 6.9 6.3 0.6 No No 45 months 
SUMMARY  
11613 
(total) 3.26 2.45* 0.99*    
nr = not reported;  * Rogula et al excluded 
a Closure of JJ mesenteric defect in the last 18 months  
b Only in the last 155 cases 
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Some authors have performed AA-LRYGB successfully without division of small bowel 
mesentery in an attempt to reduce the IH incidence by removing a potential IH space.  
Rodriguez et al. (194) performed AA-LRYGB without division of the mesentery but with 
closure of all mesenteric folds / spaces. His incidence was  1.1% .   
 
Yet another variation of the AA-LRYGB technique has been reported by Cho et al (173) 
who performed AA-LRYGB without division and without closure of the mesenteric 
defects. They report an impressively low incidence of internal hernias (0.2%) at 11 
months mean follow-up, though 2 of the 3 internal hernias they report occurred over 12 
months after surgery and it may be that later hernias were missed due to a short follow-up 
period.    In contrast, using a similar technique, Abasbassi et al (133) report a higher IH 
rate of 6.9%, with most occurring at the jejunojejunostomy defect. The higher rate of IH 
found in this study may have been due to their longer mean follow-up period (45 months) 
and differences in the surgical technique used. Abasbassi et al used a modified cut omega 
loop technique leaving a longer distance of remaining small bowel between the two 
anastomoses (GJ and JJ). Subsequently their JJ lies lower than average and in turn this 
may give rise to a larger mesenteric defect.   
 
There have been very few studies comparing the incidence of IH between AA-LRYGB 
with and without mesentery division. One such study (194) divided patients into 2 
groups; group 1 in which the mesentery of the jejunum was widely opened, the 
mesenteric defect was closed and the Petersen space was not sutured. In group 2 the 
mesentery was not divided and both, the mesenteric folds and the Petersen space were 
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closed. In group 1 14.4% developed IH and in group 2 only 1.1% developed IH.  The 
authors concluded that leaving the mesentery unopened and closing all defects 
significantly decreased the incidence of small bowel obstruction. 
 
In this Chapter, I will describe my own experience with using an antecolic antegastric 
Roux limb without division of mesentery and without closure of IH defects and its effect 
on the incidence of IH.   
 
8.2 Rationale for this technique 
We have established that IH occurs through spaces or mesenteric defects that can occur in 
3 locations with the retrocolic/retrogastric technique and in 2 locations with the 
antegastric/antecolic technique.  For this reason the majority of bariatric surgeons have 
traditionally closed mesenteric defects at the time of the primary surgery.  
 
8.2.1 Variations in IH defects 
Clinically, internal hernias can be asymptomatic or cause significant discomfort ranging 
from constant vague epigastric pain to intermittent colicky periumbilical pain to frank 
small bowel obstruction and in extreme cases leading to peritonitis from bowel gangrene. 
Similar to abdominal hernias, symptom severity relates to the duration and reducibility of 
the hernia and the presence or absence of incarceration and strangulation.    
 
We have previously demonstrated that there is an association between IH occurrence and 
time after LRYGB which may be a surrogate marker for weight loss; fat loss within the 
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mesentery may potentially allow previously suture closed spaces to partially open up. A 
loop of small bowel may then become trapped in a small mesenteric defect and lead to 
symptoms. 
 
It would be fair to assume that the smaller the mesenteric defect, the more likely it is for a 
loop of small bowel to become trapped. Whilst in larger defects, small bowel loops may 
intermittently slip in and out without even the patient having any symptoms.    
 
Thus small internal hernia defects are more likely to become symptomatic whereas large 
defects may pass unnoticed. This is also the reason why most bariatric surgeons do not 
close the Petersen internal hernia space in the antecolic antegastric technique (but will 
close this space in retrocolic retrogastric technique) as it is a large space (but smaller in 
the retro technique). 
 
The aforementioned observation poses the question – do large internal hernia spaces need 
to be closed especially as they are unlikely to cause symptoms. Champion et al were the 
first to question whether closure of all potential IH is necessary (126, 195).   
 
8.2.2 What is a defect and what is a redundant space? 
A mesenteric defect is created by the surgeon when small / large bowel mesentery is 
divided.  In contrast, a redundant space may be created when bowel loops are re-arranged 
in  position  within  the  peritoneal  cavity.  Typically  ‘spaces’  are  much  larger  gaps  than  
defects.    A  classical  example  is  the  Petersen’  s  space  created  during  LRYGB.    My  own  
141 
 
work has already demonstrated that is the most rare site of symptomatic internal 
herniation. 
 
It is therefore reasonable to ask the question if LRYGB is performed using a technique 
that does away with mesentery division, would this not reduce the rate of symptomatic 
IH?  Moreover the need to close a IH space would no longer exist as there would be no 
IH defect as such, only a large redundant space through which small bowel loops could 
freely move in and out of.  This is not a novel suggestion as some surgeons (133,173) 
have described  LRYGB without division of mesentery and without closure of 
intermesenteric spaces. Advantages of such a technique are (i) a shorter operating time by 
avoiding the time-consuming process of suturing closed all the mesenteric defects and (ii) 
reduced risk of trauma to mesenteric blood vessels during IH closure. 
 
8.3 Methods 
8.3.1 Patients 
Between 1 January 2008 and 1 June  2012, 444 patients underwent primary LRYGB by a 
single surgeon using a standard antecolic antegastric technique without division of 
mesentery and without closure of redundant spaces (IH defects are non-existent in this 
technique).   
8.3.2 Setting 
Imperial Weight Centre at Charing Cross Hospital 
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8.3.3 Surgical technique 
This is not a novel technique but it is  based  on  a  modification  of  Lonroth’s  technique  
(196).   Pneumoperitoneum was established, and the omentum and transverse colon were 
reflected, exposing the ligament of Treitz. The small bowel was divided approximately 
30 cm from the ligament of Treitz with use of an ETS-45 stapler (Ethicon Endo-Surgery 
Inc, Cincinnati, OH).   About 100 cm of the distal bowel was measured out to establish 
the length of the Roux limb. A side-to-side functional end-to-side enteroenterostomy was 
performed to create the anastomosis between the biliopancreatic and Roux limbs.  The 
gastric pouch was fashioned by using a transverse application of an ETS-45 stapler (3.5-
mm cartridge), followed by multiple vertical applications of the stapler to create a 
completely isolated proximal pouch with a volume of approximately 15 to 30 ml. A 
vertical split in greater omentum was made. The stapled end of the Roux limb was then 
positioned antecolic antegastric beside the gastric pouch and a side-to-side functional 
end-to-side gastrojejunostomy performed. The pneumoperitoneum was then released and 
the trocars were withdrawn. 
8.3.4 Data collection 
A retrospective review of the medical records of the 444 patients was conducted and the 
following  information  recorded:  the  patient’s  age,  sex,  and  preoperative  BMI,  the  amount  
of postoperative weight loss (percentage of excess body weight lost [%EBWL]); the 
incidence of symptomatic IH and the postoperative time to presentation with IH 
symptoms; and the location of the IH. The information obtained on patients with IHs was 
compared with that on patients without IHs.   
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A second analysis also compared the incidence of IH in this series with a historical group 
of 2215 retrocolic retrogastric LRYGB (with mesentery division and IH defects closure) 
performed at Strong Health Bariatric Center, Highland Hospital who developed 
symptomatic internal hernia requiring operative intervention between Jan 1, 2000 and 
September 15, 2006.  For each case, age, gender, weight, body mass index (BMI) and 
time gap from initial surgery to secondary presentation with internal hernia were 
recorded. 
8.3.5 Statistical analysis 
GraphPad Instat version 3 (GraphPad Software Inc., USA) was used to perform statistical 
analysis. The data are expressed as mean +/- standard deviation (SD).  Unpaired t test 
was used to compare the different means in the IH group versus non IH group. Chi-
square test was used in the final analysis to compare the IH rate in the AA-LRYGB 
versus retrocolic retrogastric LRYGB groups. Odds ratios were calculated following Chi-
square statistical analysis.  A p value less than or equal to 0.05 was considered to 
represent a significant difference.  
8.4 Results 
During the postoperative observation period, 2 patients (DCA, MO) presented with 
abdominal pain, vomiting, or a combination of these symptoms and were found at 
relaparoscopy to have an IH; thus, the overall IH rate in the series was 0.45%.  Another 
patient SW underwent reoperation for a marginal ulcer where an incidental internal 
hernia was noted at this surgery, but as this was non-symptomatic, and not the reason for 
presentation,  its  occurrence  will  not  be  included  for  the  purpose  of  this  study’s  results. 
 
144 
 
The mean follow-up time in the entire series of 444 patients who underwent LRYGB was 
43 months, range 16-70 months. 365 out of the 444 participants were contacted by 
telephone at the time of analysis to ensure they had not presented to any other unit with 
IH, this represents a follow-up rate of 82%.   The remaining 79 patients were non-
contactable. 
 
Table 7.2 shows demographic and follow-up data on the patients presented in this series: 
(i) No internal hernia and (ii) internal hernia. Comparing the 442 patients in whom 
symptomatic IHs did not occur with the 2 in which IH did occur, there was no statistically 
significant difference in baseline patient demographics (except age), mean follow-up 
time, amount of postoperative weight loss in both groups. Interestingly, the % EBWL in 
the IH group at the time of reoperation for IH is 78%. The average time interval between 
initial surgery and reoperation for IH is 355 days.  In the non-IH group, the %EBWL at 
364 days is 57% ±17 (mean ±SD).  Although this difference does not quite reach 
statistical difference (p=0.08) due to the uneven group sizes, one can see there may be an 
association between those patients having the most weight loss and symptomatic internal 
hernia occurrence.   
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Table 7.2. Baseline patient characteristics 
Characteristic No internal hernia (n=442) Internal hernia (n =2) p value 
Age (yr) 
Mean ± SD 44 ±10 28 ±6 0.013 
Range 18-70 24-33  
Gender (n) 
Women 327 1 - 
Men 114 1  
Weight (kg) 
Mean ± SD 132 ±24 177 ±8 0.004 
Range 80-230 172-183  
Excess body weight (kg) 
Mean ± SD 71 ±21 106 ±10 0.010 
Range 23-164 98-113  
BMI (kg/m2) 
Mean ± SD 47 ±7 55 ±3 0.11 
Range 33-77 53-57  
Weight at year 1 postop 
Mean ± SD 90 ±18 108 ±3 0.16 
Range 44-166 106-110  
%EBWL at 1 year postop 
Mean ± SD 57 ±17 65 ±3 0.51 
Range 17-116 63-68  
BMI (kg/m2) at 1 year postop 
Mean ± SD          33±7 
 
32 ±6 34 ±2 0.64 
Range 18-55 33-35  
BMI = body mass index.; %EBWL = % excess body weight loss 
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Table 7.3 gives further details on the patients who presented with IH. The mean time until 
postoperative presentation with abdominal symptoms was 22 months for patient MO. MO 
was noted at relaparoscopy to have an obstructed loop of small bowel (Roux limb) stuck 
in the space between the mesentery of the biliopancreatic limb and the mesentery of the 
common channel. Due to difficulty in obtaining good laparoscopic views (bowel very 
dilated), a small laparotomy was made and the trapped bowel released. The space 
between the mesenteries was closed with interrupted sutures. MO made an excellent 
recovery and was discharged home after 3 days. Patient DCA presented at 19.5 months 
postoperatively with symptoms but at relaparoscopy, no abnormality was noted. DCA 
then represented 6 months later (a total of 25.5 months from the index surgery) with 
symptoms and at relaparoscopy a obstructed small bowel loop (Roux limb) was seen 
stuck in the Petersen space. This was successfully reduced laparoscopically and the space 
closed with interrupted sutures. DCA was discharged home the next day after surgery. 
 
Table 7.3   Internal hernia patient characteristics 
Characteristic Patient CDA Patient MO 
Preoperative weight 183 172 
Weight at reoperation (Kg) 94 95 
BMI at reoperation 28 29 
%EBWL at reoperation 78 78 
Time period between 1st operation 
and reoperation for IH (days)  
407 303 
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Next a comparison was made in IH rates in the antecolic antegastric LRYGB non-
mesenteric division, non IH closure group with a historical sample of retrocolic 
retrogastric LRYGB with mesenteric division, with IH closure.  
 
The IH rate among the 2215 patients who had a suture closure after mesentery divided 
retrocolic retrogastric LRYGB was 2.4%, whereas that among the 444 AA-LRYGB 
patients in whom no IH spaces were closed and no mesentery divided was  0.45%; but the 
difference between the rates was not statistically significant.  Among the 54 patients in 
whom IHs occurred, the baseline patient demographics (except pre-operative weight), 
overall follow-up time, amount of postoperative weight loss, and time to presentation 
with an IH were similar in both groups (Table 7.4).   
 
Table 7.4   Internal hernia patients’ characteristics: Group 1 antecolic antegastric (non-
mesenteric division non IH closure,) vs. Group 2 retrocolic retrogastric (with mesenteric 
division and IH closure) 
Characteristic Group 1 Group 2 p value 
Number of patient in series 444 2215  
Number of patients with IH 2 52  
Internal hernia incidence (%) 0.45 2.4 0.01* 
Preoperative weight (Kg) 177 ±8 138 ±25 0.03 
Weight at reoperation 94.5  ±0.7 94.1 ±24 0.98 
BMI at reoperation 28.5  ±0.7 34.1 ±8 0.33 
%EBWL at reoperation 78  ±0.4 59 ±25 0.29 
Time period between 1st operation 
and reoperation for IH (days)  
355 ±73 411 ±348 0.82 
* Chi-square test;  
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8.5 Discussion 
Closure of internal hernia defects during LRYGB remains a controversial issue amongst 
bariatric surgeons. Many surgeons favour routine closure whereas others have found no 
difference in internal hernia rates by leaving these spaces open. The current study goes 
some way in answering the question do internal hernia defects created at the time of 
LRYGB need to be closed?   
 
The results of this work demonstrate that by using an antecolic antegastric approach 
without division of small bowel mesentery, the incidence of internal hernia is lower than 
the incidence observed when the surgeon routinely closes all internal hernia defects in the 
retrocolic retrogastric LRYGB. One potential explanation for this rather paradoxical 
finding is that in the non-mesentery division technique, large redundant spaces are 
created through which loops of small bowel may displace in and out without becoming 
stuck. In cases where IH defects are routinely closed, gaps in the mesentery may develop 
as a result of weight loss, thus, trapping small bowel loops. 
  
In the sample population presented and using the technique described of antecolic 
antegastric non-mesentery division LRYGB, only 0.45% developed symptomatic internal 
hernia requiring surgery. This is with a mean two-year follow-up with 82% follow-up 
rate. This is less than the 2.4% internal herniation rate seen in a previous comparable 
historical control of retrocolic retrogastric LRYGB patients. The 0.45% IH rate in our 
AA-LRYGB cohort compares favourably with two other AA-LRYGB studies using non-
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mesentery division non-mesentery closure technique (6.9%116 , 0.2%120). Although our 
sample size was not as large as some of the other studies, the mean follow-up time of 
three and a half  years with 82% follow-up rate is sufficient, in our opinion, for all 
potential cases of IH to be manifest. Some previous reports do not benefit from the same 
length of follow-up. 
  
Furthermore, we have identified a possible association between the amount of weight loss 
after LRYGB and symptomatic internal hernia occurrence. This is similar to the study of 
Schneider et al (197), who reported that a significant number (46.5%) of their patients 
who developed IH experienced a period of rapid postoperative weight loss. Abasbassi et 
al (133) also noted in their series of AA-LRYGB a tendency for development of IH in 
patients who have a high excess weight loss during the first 3 months after surgery. 
 
Due to the retrospective nature of the study, various limitations are expected. One such 
limitation is the follow-up period, which may still be too short and potential future 
internal hernias might have been missed in this cohort. This, in my opinion, is unlikely as 
previous authors have documented that the vast majority of internal hernias occur around 
14 months after LRYGB. The mean follow-up period in this study was 42 months with a 
range of 16 to 70 months.  Unfortunately there was a loss in follow-up of 18% of the 
study population.  However I do not think this would have had a major impact on the IH 
incidence as the Imperial Weight Centre is the largest bariatric unit in the South East of 
Engkand and 99% of complications seen after bariatric surgery tend to present back at 
this hospital or get transferred in.   Indeed most bariatric surgeons are very good at 
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notifying colleagues of any complications seen after surgery.  Thus even if a patient from 
this sample population presented to a different unit, in all likelihood, I would have been 
informed about at the very least or accepted the patient back as a transfer at best.   
 
A further limitation of this study is that certain patients from our study cohort could have 
had asymptomatic internal hernias.  In fact one patient in the cohort was indeed found to 
have an IH during surgery for another problem. One would argue that if they are not 
symptomatic then it does not make any difference if IHs are picked up or not. Lastly, 
bariatric surgeons who routinely close internal hernia defects would argue that spending 
another 10 to 20 minutes to close these defects adds little time to surgery but saves 
patients from requiring re-surgery in the future. This study provides evidence in support 
of the opposite argument – in that seemingly closure of IH is associated with a higher 
symptomatic  IH incidence from the postulated reopening of mesenteric defects seen after 
weight loss.  Furthermore, one must not forget that the surgical technique employed in 
closure of the defects may also be associated with adverse events. These include 
mesenteric bleeding and haematoma, kinking and obstruction at the entero-entero 
anastomosis. 
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CHAPTER 9 
 
9. DISCUSSION AND CONCLUSIONS 
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Whereas the first half of this thesis concentrates on providing descriptive statistics and 
trends based on one of the largest series of LRYGB.  The second half of the thesis 
focuses on the effect of altering surgical technique in order to minimise the commonest 
complication after LRYGB, namely SBO.  Initially I have looked at altering individual 
steps involved in the surgery which would theoretically reduce the incidence of IH or 
roux constriction.  Following on from this, I have used a more analytical approach (root 
cause  analysis)  in  order  to  try  and  establish  what  are  the  ‘errors’  that  may  occur  intra-
operatively that may lead to the complications of  IH and roux compression.   If bariatric 
surgeons are aware of these errors then focussed attempts can be made to try and 
minimise these.  In the final chapter, by using an antecolic roux limb without cutting any 
mesentery and closing any defects, I have altered my own surgical technique substantially 
to try and completely eliminate IH and roux compression.  I have shown a substantial 
reduction in IH using this modified technique. 
 
The next few paragraphs will summarise some of the key findings from the research 
presented in the thesis. 
 
I have established that following LRYGB, SBO occurs with an overall incidence of 
4.38%.  In order to come to this conclusion, a population of over 2000 LRYGB cases was 
searched for reoperations and amongst these those for SBO.  This is the first time such a 
large study population has been used to establish the incidence of SBO after LRYGB.  
This makes SBO one of the commonest complications after this surgery.  I was also able 
to scrutinise the medical records in order to some other facts, such as, most of the patients 
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in our series presented with abdominal pain, which was documented in 82% of patients.  
Other common presenting symptoms included nausea and vomiting.  
 
By detailed review of all the cases of SBO found in the study population, I established 
that the most common cause of obstruction in our series was internal hernias seen in 53.9 
% of SBO cases.  The second most common cause of intestinal obstruction was scar 
induced stricture of the Roux limb as it passed through the mesocolic window, 
encountered in 20.5%. Surprisingly, adhesion induced obstructions which usually 
comprise the leading cause of post-op bowel obstruction in open surgeries comprised 
only a small fraction of patients (13.7%).  This is indeed a very important finding as most 
surgical textbooks traditionally, and even now, still mention adhesions as being the main 
cause of bowel obstruction after abdominal surgery.  This work challenges this 
commonly held view and draws attention to the fact that in the laparoscopic era, 
adhesional bowel obstruction has been replaced with bowel obstruction from other causes 
(IH and roux limb obstruction as characterised in this thesis).  Surgeons who are not 
practising bariatric surgery need to be acutely aware of this in case they are faced with a 
post gastric bypass patient with abdominal pain. 
 
Internal hernias are a known complication after LRYGB with an incidence of around 2% 
in the present series which is in keeping with other studies (51). This work’s  strength  is  
that it  documents one of the largest reported series of internal hernias accrued over a six-
year period. The location of internal hernias has been documented with transverse 
mesocolon hernias (46%) commonest followed by enteroenterostomy (40%) and then 
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Peterson’s  space  hernias (14%).   The strength of this analysis comes from the large 
number of cases reported in our series as well as the long follow-up we have, hitherto not 
seen in the published literature. 
 
We demonstrate that internal hernias, on average, present some 14 months after the initial 
surgery. By this stage, the average weight loss has been around 44 kg with the majority of 
patients experiencing 52-66%EBWL (mean 59%).  The importance of this is twofold.  
Firstly it re-emphasizes  the point that LRYGB patients need longterm follow-up as IH 
typically occurs a year after the index surgery.  Typically in surgical patients, the vast 
majority of postoperative complications take place within the first 30 days.  Our data has 
shown that the most common complication after LRYGB surgery actually occurs more 
than a year after  surgery.  Secondly the timing of IH occurrence coincides with the time 
of maximum weight loss seen which in turn lends substantial weight to the hypothesis 
that IH occurs subsequent to loss of tissue (fat) from the mesentery allowing previously 
closed spaces to open up, allowing gaps for small bowel loops to become trapped in.  A 
finding in chapter 8 that adds strength to this hypothesis is the observation that in the 
antecolic antegatsric non mesentery division non closure of IH space cohort of patients, 
the two patients that developed IH were the ones in fact the greatest weight loss seen in 
the cohort by the time of reoperation. 
 
Patients often present with non-specific symptoms with a diverse differential diagnosis. 
Hence it is useful to know which diagnostic imaging test offers the most likelihood of 
correctly identifying IH.  The results of this work indicate that CT scanning with 
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intravenous and oral contrast correctly identified IH in 92% of cases. In equivocal cases, 
the addition of UGI study increases the diagnostic rate to 100%.  Once again this study 
finding is of great significance as it allows clinicians to choose the most appropriate 
imaging modality when faced with LRYGB patients presenting with abdominal pain.   
 
Our results demonstrate that narrowing at the transverse mesocolon rent is the second 
commonest cause of SBO in retrocolic LRYGB.  We report an incidence of  0.9% 
incidence in 2215 patients, one of the largest documented series of retrocolic LRYGBs, 
which benefits from an extensive mean follow-up period (3 years).   
 
We demonstrate that upper GI contrast study is the most appropriate imaging modality 
for making the diagnosis.  95% of cases in our series were successfully diagnosed pre-
operatively using this modality. Based on our findings, we advocate the use of upper GI 
series when Roux limb compression is suspected.   
 
Our time-to-event analysis demonstrates that unlike internal hernias, which tend to occur 
later in the clinical course (a year after surgery), Roux limb obstruction occurs much 
earlier after LRYGB.  Once again this finding  adds strength to the hypothesis of reduced 
intraperitoneal fat leading to larger mesenteric defects and thus greater herniation risk.   
On the other hand the observed time gap of 48 days to Roux limb obstruction 
development would be consistent with scar tissue development at the mesocolic rent 
compressing the Roux limb.    The difference in time to presentation for these two causes 
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of SBO after LRYGB is a very important finding as it aids the clinician to make the 
correct diagnosis. 
 
Having established the incidence, timing, clinical features and imaging characteristics of 
IH and roux compression, an attempt has been made to see if variations in LRYGB 
surgical technique can reduce IH and roux compression incidence. As such, we 
ascertained that using interrupted stitches in place of a continuous stitch to close the 
mesocolic window appears to reduce the incidence of Roux limb compression.  Another 
finding has been that an antecolic Roux limb by definition obviates the need to create a 
window in the transverse mesocolon and this in turn eliminates this site as a potential area 
for herniation.  Although the aforementioned should not come as a surprise, what my 
research has shown is that the magnitude of this effect.  My work  demonstrates a 
fourfold increased risk of internal hernias when a retrocolic Roux limb is used.  We also 
evaluated the effect of switching from interrupted closure to running closure of the 
enteroenterostomy  mesenteric  defect  and  Peterson’s  space. This did not appear to have 
any effect on IH incidence, but may have been due to small sample size for this part of 
our analysis.   
 
On the other hand, when bioabsorbable polymer SLR was applied when dividing the 
bowel and mesentery, without closure of the mesenteric defects thereby created, there 
was a significantly lower IH incidence than in patients who had suture closure of the 
mesenteric defects (0.8% vs 2.9%).  This study is the first to observe usage of SLR in 
LRYGB associated with a decreased  IH rate.  It is my hypothesis that the presence of 
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SLR on the cut edges of the mesentery evokes local adhesion formation and tissue fusion 
that creates a bond stronger than that provided by sutures, which may cut through the 
mesenteric tissue when the amount of fat decreases with weight loss. This bond  seals the 
defects created at surgery and thereby decreases the rate of post-LRYGB IH formation.  
This is a new found effect of SLR and the manufacturers have already been contacted 
informing them of this.  Therefore , SLR can therefore be used in LRYGB procedures not 
only with the objective of decreasing gastrointestinal bleeding but also with the aim of 
reducing the postoperative IH rate.  
 
Whereas chapter 6 was concerned with alterations in various steps in LRYGB surgery 
and the impact on IH incidence, chapter 7 shifts the focus onto analysis of intraoperative 
errors.  Currently, there is little knowledge on the surgical errors that may lead to internal 
hernia formation and Roux limb compression. Admittedly, even if surgical performance 
is flawless, weight loss after surgery may lead to pulling on the sutures placed in the 
mesenteric defects. Similarly, Roux limb compression may still occur due to cicatrix 
formation. However, surgical performance and the errors made during surgery may be a 
contributing factor in the incidence of complications. This study has demonstrated that by 
submitting operative videos to OCHRA, errors can be identified and can be correlated 
with their resultant complications; in our specific study, a missed stitch securing the Roux 
limb mesentery to the transverse mesocolon appears to play a role in the occurrence of 
internal hernias and Roux limb compression. This constitutes a procedural error and thus 
highlights the need to reinforce operative rules and indicates that surgical training of this 
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procedure may benefit more by ensuring proper sequential conduct of the operation 
(menu-driven execution). 
 
The studies conducted thus far clearly demonstrate how changes in intraoperative 
technique can affect the incidence of IH and roux compression.  It was evident to me that 
the antecolic roux limb routing would be by far preferential by eliminating completely the 
risk of roux compression. In addition the antecolic routing removes the possibility of IH 
at the transverse mesocolic rent reducing the overall IH incidence. In order to reduce the 
incidence of IH further, I decided to alter my technique and perform LRYGB without 
dividing any mesentery.  The final part of this thesis examines this further.. Furthermore 
not closing any potential herniation sites would keep any redundant intermesenteric 
spaces wide enough to allow loops of bowel to slip in and out with little risk of 
entrapment causing SBO.  Chapter 8 demonstrates that by using an antecolic antegastric 
approach without division of small bowel mesentery and non-closure of the mesenteric 
spaces, the incidence of internal hernia can be substantially reduced..  In fact what is 
perhaps most interesting is that the incidence of IH using this modified LRYGB 
technique is substantially lower than in the standard LRYGB technique where most 
surgeons are, through tradition, indoctrinated into closing IH spaces.  The findings from 
this research challenge surgical dogma.  In fact by closing IH spaces, surgeons may be 
doing a disservice to patients and paradoxically increasing IH incidence.  I realise this is 
counter intuitive but the observations from my research which are scientifically valid 
would certainly warrant a re-examination of the common practice of closure of IH.   In 
the field of surgery, many traditions have been followed from one generation to the next.  
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Examples are routine use of nasogastric tubes;  mechanical bowel preparation;  irrigation 
of the abdomen;  bowel obstruction: never let the sun set on it.  All of these, through 
scientific research, have been shown to make no difference to surgical outcomes.  
Similarly it is my position from the research presented that routine closure of IH spaces 
can actually lead to a higher incidence of IH and that using the modified LRYB technique 
described can actually minimise IH rates.  
 
 
 
Study Limitations 
The primary limitation of this work is that it is a retrospective analysis (apart from 
chapters 7 and 8), and it is therefore liable to all the potential factors that limit 
retrospective studies 
 
The  majority  of  the  data  was  captured  from  patients’  medical records and in particular 
operative notes from two hospitals where I worked – Strong Health Bariatric Centre in 
Rochester, New York and the Imperial Weight Centre, London.  In both units, data from 
the notes was extracted  according to a standardized template thus reducing the chance of 
missing data.  
 
The internal hernia and Roux constriction incidences were dependent on  postoperative 
patients presenting with symptoms and signs warranting treatment. It is possible that the 
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actual incidence of internal hernia may be higher if one includes cases that have not 
become symptomatic enough to trigger a hospital visit.  
 
Accurate calculation of the incidence of internal hernias also depends on patients 
returning to the host institution  and  not  presenting  to  other  hospitals’  emergency  
departments. At Strong Health Bariatric Center, where part of this study was performed, 
the follow-up rate after bypass is 80%.  The follow-up rate from the Imperial Weight 
Centre study was 94%.  The mean follow-up period for the data presented was 36 months 
(Strong Health Bariatric Center) and 25 months (Imperial Weight Centre).   
 
Lastly, errors may be introduced into the analysis from combining the outcomes of 
different surgeons. All the surgeons whose results were used in this study follow a 
standardised operative technique with no deviation from one case to the next and differ 
amongst each other only in those steps of surgical technique that were the subject of 
assessment. 
 
Conclusions 
The work presented in this thesis comprises one of the largest series of bowel 
obstructions post LRYGB that has been studied.   Through a rigorous retrospective 
analysis of prospectively collected data, I have successfully obtained important facts 
concerning this not uncommon complication following gastric bypass surgery.  
Significantly, using OCHRA for the first time in bariatric surgery, I have established 
objective evidence of where the occurrence of a surgical technical error is significantly 
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associated with an adverse outcome – IH.   This work goes a long way in challenging 
what has been a surgical dogma that all IH defects need closure.  The work presented in 
fact strongly suggests that by using an antecolic antegastric technique without mesenteric 
division and mesenteric space closure, the incidence of IH is actually lower than in those 
cases where the latter has been performed. 
 
Future Directions 
Now that it has been established that non-division of the mesentery and non-closure of 
intermesenteric spaces is associated with reduced IH rates, this creates the opportunity for 
further work in this area.  In particular a randomised controlled trial examining AA-
LRYGB with mesentery division/closure compared to AA-LRYGB without mesentery 
division/closure would certainly be possible and lead to level 1 evidence further 
supporting the results of this thesis.   Furthermore by recording all the laparoscopic 
operations performed in both arms, all those cases with an adverse outcome could be 
subjected to OCHRA analysis.  This would yield objective evidence of where in the 
surgery are the key steps that require meticulous performance in order to keep 
complication rates at a minimum.  
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APPENDIX 1: data input form with sample data extract 
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APPENDIX 2:  Frequency and nature of the errors observed in the OCHRA study [ raw data] 
 
